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PREFACE
This work provides a comprehensive assessment of surgical implant and tissue
interface stability. The implants have been evaluated under different conditions
within distinct tissues including cartilage and bone. The first chapter, literature
review, offers a broad discussion of current challenges associated with implant
placement in tissues as well as novel techniques that have been found to improve
the stability of the implant and have a positive influence on the long-term
integration.
Placing an implant in tissue leads to injury which must heal over time and healing
results in the long-term integration of the implant. Several techniques have been
described to improve the integration process, which essentially improves the
healing of injured tissue. Some of these techniques concern novel implant designs
which increase tissue and implant contact surface and therefore reduce focal
stresses applied during insertion, distributing them over larger tissue area. Another
common technique to improve long-term integration is coating the implants with
various kinds of bioactive agents. Popular examples include growth factors and
minerals which have been known to directly stimulate the healing process.
The following two chapters relate to ex-vivo research conducted on several
implants placed in cartilage and bone. Suture and thyroid cartilage interface
stability was evaluated with a single pullout to failure test on the laryngeal
advancement constructs. The conclusions of this study lead to improved implant
design which showed higher primary stability than the existing suture. The
succeeding study evaluated osseointegration of screw implants placed in a
dynamic compression plate to stabilize tibial defect using the peak reverse torque
(PRT) method. Self-tapping screws were found to have better osseointegration
after 60 days of loading as compared to non-self-tapping screws. Another
conclusion of this study revealed that peak reverse torque can be used to measure
the axial stability of an orthopedic plate.
Two final chapters relate to in-vivo studies and focus on the osseointegration of
novel technology tissue scaffolding. Osseointegration of temporary bone fillers is
an absolute prerequisite to enhance bone regeneration. Scaffolds were evaluated
without additives in the goat and equine animal model as well as coated with
recombinant human bone morphogenetic protein-2 and seeded with allogenic
caprine mesenchymal stem cells in a goat animal model.
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ABSTRACT
The stability of implant and tissue interface is vital for a long-term implant
integration with adjacent tissue and directly impacts the surgical outcome.
Literature provides comprehensive research conducted on implants engaged in
soft as well as in hard tissues evaluating further their stability. The results helped
establish several factors that have been found to be of importance in interface
stability.
This comprehensive work incorporated research projects with the main focus on
implant and tissue interface stability, which were evaluated using biomechanical
assessment tools such as pullout as well as reverse torque measurement tests.
Implants were evaluated under ex-vivo conditions, immediately after placement
within the tissue as well as under in-vivo conditions, 2- and 6-months following
implantation surgery in the goat and equine animal model.
In the following studies, the stability of interface has been found to be primarily
influenced by several factors, including the amount of load experienced by the
implants, stress applied by the implants to adjacent tissue as well as bioactive
coatings. Furthermore, the studies included in this dissertation offer novel
technologies that aim to improve interface stability-enhancing implant integration
and tissue regeneration. These technologies concern novel design laryngeal
clamps used to improve stability of laryngeal advancement constructs and novel
technology polyurethane scaffolds coated with bioactive nanophase
Hydroxyapatite to significantly enhance bone regeneration.
The research incorporated in this work found that increased tissue and implant
contact areas resulted in increased interface stability and better integration.
Furthermore, incorporation of bioactive coatings in bone scaffolds significantly
enhanced osseointegration ultimately resulting in improved tissue regeneration.
Laryngeal clamps with higher cartilage to implant contact area were superior in
biomechanical testing as compared with standard suture. Self-tapping screws with
an increased bone to implant contact area revealed higher osseointegration after
60 days of loading as compared with Non-self-tapping screws. Bioactive coatings
such as nanophase Hydroxyapatite with decellularized bone particles or
Mesenchymal Stem Cells were found to significantly enhance osseointegration of
bone scaffolds and resulted in improved bone regeneration.
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CHAPTER ONE
SURGICAL IMPLANT AND TISSUE INTERFACE. LITERATURE
REVIEW
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Introduction
Surgical implants are routinely used in soft tissue as well as in orthopedic surgery,
with a very wide range of applications. Common examples include screws, plates,
and suture anchors used in orthopedics as well as sutures used in soft tissue and
scaffolds used in tissue regeneration. Integration between implant and tissue is
vital for construct stability and directly influences short- and long-term surgical
outcomes. Therefore, current research aims to continuously improve the
integration process. Optimally, implants will not lead to adverse reactions
associated with surgery as well as will stimulate the integration process. Every
implant insertion leads to tissue injury, which heals over time resulting in following
implant integration. The integration process is associated with a strengthening of
the implant-tissue interface. Several factors have been found to negatively as well
as positively influence this process in distinct tissues. This literature review
provides a comprehensive look into current knowledge about implant and tissue
interface and novel approaches to strengthen the interface. Last paragraphs
review approaches for biomechanical testing used to evaluate the integration
process.
Surgical Implant and Cartilage Interface
Implant integration within cartilage is challenging due to tissue avascular nature as
well as dense and rich in proteoglycans extracellular matrix (EM), strong forces
applied to joint surface during physiologic joint motion and low coefficient of friction
(1,2). Implantation process causes an injury within the tissue which further results
in death of adjacent chondrocytes (2). Because of pour vascularization, material
which would facilitate regeneration process is not accessible. This includes
chondrogenic progenitor cells from circulating blood and marrow as well as
resident chondrocytes which cannot migrate through the dense EM. All those
factors have been found to negatively affect the integration process.
Anatomically, articular cartilage consists of chondrocytes that are surrounded by
an extensive extracellular matrix which takes up to 90 % of tissue volume and
contains primary water, aggrecans as well as type II collagen (1). Tissue is
organized in four distinct areas which have been defined as the superficial zone,
the intermediate zone, the radial zone and the calcified zone. All the anatomic
structures have been involved in implant and tissue interface strengthening.
Pour ability of cartilage to regenerate chondral lesions has been confirmed on the
lesions bigger than 6 mm in diameter (3). The osteochondral lesions have a better
healing prognosis since the injury extends to subchondral bone causing bleeding
(1). Blood coming from bone provides growth factors, mesenchymal stem cells and
platelets necessary for the regeneration process. The blood clot formed after
osteochondral injury can fill the defects with diameter below 23 mm in their entirety
(1). Tissue repair is a complicated process which results in a transient
fibrocartilaginous tissue as a replacement for hyaline cartilage (1). Fibrocartilage
2

is mechanically inferior to hyaline cartilage due to higher collagen I to collagen II
ratio as well as lower proteoglycan content (4). It may appear that defect is healed
after replacing it with fibrocartilage, however due inferior mechanical properties,
microcracking will occur around margins between regenerated tissue and hyaline
cartilage which will ultimately lead to the full thickness fissures (5-7). Continuous
transition on interface of the implant is vital for the integration process because it
provides chondrocyte viability (1).
Implant integration within cartilage is highly dependent on collagen fibers
attachment to the surface of an implant as well as on chondrocyte migration and
repopulation the interface. The implants placed in subchondral bone achieve
higher stability than those placed only in cartilage which commonly result in a
higher grade of integration (8). Furthermore, it was shown that the size, modulus,
coefficient of friction, and poisons ratio of the implant is critically important in longterm integration (8). The implants with a size of 5 mm lead to a very small tissue
damage and result in successful fixation within surrounding tissue (8). Chondral as
well as osteochondral implants with lower material modulus, and higher coefficient
of friction caused more damage to the interface due to higher shear stresses
related to joint motion. The increase in Poisson’s ratio was associated with a higher
damage of surrounding tissue in implants placed in osteochondral defects as
compared with the implants placed in chondral defects. The differences in
coefficient of friction and poisson’s ratio between cartilage and the implant have
been attributed to different organization in collagen fiber distribution as well as
different collagen content and crosslink density (9).
Implantation process has been associated with tissue injury which under in-vitro
conditions resulted in a zone of cell death characterized by a band of necrosis 100200 microns wide. The necrosis was followed by a gradual cell apoptosis over 14
days period and it extended the band up to 400 microns from the center of injury
(10,11). Surviving cells outside the necrotic zone repopulate the matrix but they
can only attach to the same lacunae as daughter cells and are not able to invade
entire matrix (11). Because of the limitations in resident chondrocytes migration,
delivering an implant with new chondrocytes can enhance the integration process
(12-14). According to one study, autografts should contain between 5 and 30
million chondrocytes depending on the size of the defect (14). The source of new
cells, including animal species from which the graft was harvested as well as the
origin of implanting graft (auricular cartilage, tracheal cartilage etc.) are in a critical
importance (12,13). The presence of even a small number of senescent cells within
a graft has been associated with a negative influence on regeneration due to the
pro-inflammatory properties, catabolic phenotype as well as existence of
metalloproteinases (15). Cell apoptosis can be inhibited using caspase inhibitors
such as ZVAD-fmk, however the current results are not convincing (16).
Collagen network has been also found to be important in creating implant and
tissue interface (1). Integration process has been attributed to direct attachment of
3

collagen fibers to the surface of an implant (1). It was found that fusion of distinct
cartilages with different developmental stages may cause lysyl-oxidase mediated
collagen crosslinking which negatively impacts integration (17). Modulation of this
process before implantation using β–aminopropionitrile, stimulates collagen
maturation and increases its adhesive strength (18). Disruption of collagen fibers
either through injury or enzymatic digestion leads to 10 times accelerated cellular
proliferation and increased chondrocyte mobility which further repopulate the
interface enhancing integration and mechanical strength of an implant (19,20). The
most common enzymatic approaches include treatment with collagenase,
chondroitinase ABC, trypsin or hyaluronidase (19-27). Furthermore, enzymatic
treatment improves proteoglycan synthesis for a longer duration (24). It was also
found that chemotactic agents such as insulin like growth factor-1 (IGF-1) and
recombinant human bone morphogenetic protein -2 (BMP-2) boosted cell
migration (28,29).
Several adhesives which improve implant stability have been described and the
most commonly used from them is fibrin glue (30). Chemically modified chondroitin
sulphate biopolymers with metacrylate and aldehyde groups to connect
biomaterials and tissue protein have been also described (30). Collagen adhesion
protein (CNA) is a bacterial surface protein synthetized by Staphylococcus areus
to attach to monomeric chains of collagen (31,32). It is a well characterized protein
with a high binding affinity to collagen type I and type II (31,32). Other examples
of biologic adhesives include cationized gelatin (33) RGDs (34), multiple peptides
in combination (such as RGD, YIGSR, and IKVAV) (35), and extracellular matrix
proteins with or without growth factors such as collagen II and ﬁbroblast growth
factor (36). The molecules locally presented in synovial fluid which provides
lubrication within the joint, included PRG4 (SZP/lubricin/megakaryocyte
stimulating factor precursor) have been also associated with implant cartilage
integration (37).
Surgical Implant and Ligament Interface
Similarly, like in cartilage, integration of an implant within ligament is challenging
due to slow healing rate. This dense tissue is primarily composed of water (70%),
collagen (25%) and matrix components which contain proteoglycans, fibronectin
(4%) and tenocites (<1%) (38). Tissue structure is highly organized with tenocites
as well as collagen fibers aligned longitudinally and interacting with one another
through gap junctions, primarily connexin 32 and 43 (39). Slow healing has been
attributed to limited vascular supply which is provided only in epiligament (38).
Blood flow through the tissue is regulated by autonomic nerve supply and it may
be increased during inflammation and tissue repair (40).
Ligament healing leads to a scar formation, which is known to have inferior tensile
strength and viscoelastic properties as compared with native ligament tissue
(41,42). Healing process corresponds to osteochondral healing and it is initiated
4

with internal bleeding as well as blood clot formation (41). During this time, tissue
debris resulted from injury is being removed and angiogenic cells together with
fibroblasts are attracted to produce matrix consisting of fibrous connective tissue.
Collagen ratio in a scar is changed and contains predominantly collagen type III,
V, and VI with significantly lower amount of type I (41). During slow further
regeneration (up to 2 years), number of cells and vessels decreases, and the
collagen alignment improves as well as collagen ratio changes to predominantly
collagen type I (41).
Due to slow healing rate of injured tissue and significantly inferior mechanical
properties, ligaments are not capable to resist physiologic tensile stresses and
require immediate stabilization. Current regenerative research has targeted mostly
collagen cross-links, predominant presence of type V collagen, and scar tissue
formation (42-44). Level of collagen cross-links have been shown to decrease over
1 year after injury what resulted in the inferior mechanical properties of scar tissue
(42). Predominant presence of type V collagen has been further attributed to a
smaller fiber diameter due to smaller size fibrils (43). The inferior properties of scar
tissue have been associated with presence of non-tensile structures such as blood
vessels, fat cells, disorganized collagen fibers and cellular infiltrates (mostly
fibroblasts) (44).
Regenerative research has found that cellular infiltrate within scar tissue are well
responsive to growth factors, such as platelet derived growth factor (PDGF), basic
fibroblastic growth factor (bFGF), epidermal growth factor (EGF) as well as
transforming growth factor beta (TGF-beta) which stimulate their proliferation and
collagen synthesis (44-46). Platelet rich plasma as a blood derived product,
contains rich amount of majority of above-mentioned growth factors and therefore
it has been shown to also stimulate the regenerative process (46). Further
bioactive agents positively influencing ligament and tendon regeneration include
hyaluronic acid (HA), collagen as well as mesenchymal stem cells (46).
Besides the bioactive agents used to stimulate tissue regeneration, several
implants have been utilized to provide immediate stabilization of injured tissue and
common examples include sutures and allografts. Sutures are used to reattach the
ends of a torn ligament to reduce gap between the fragments and increase contact
surface. Allografts are used in ligaments containing a defect to also reduce gap
and increase contact surface. Gap size and decreased contact surface have been
associated with a higher amount of scar formation which has a negative influence
on strength of healed ligament up to 2 years after the injury (47).
Suturing process generates direct tissue trauma and cell death in tendons (48).
Necrosis creates acellular zone in adjacent tissue within 72 hours which may
persist for up to 1 year (48). This phenomenon was explained with tension applied
across the suture grasp (49). Healing was not observed in the acellular zone for
up to 1 year after surgery due to a pour vascularization, dense extracellular matrix
5

and aligned tendon cells (49,50). Acellular zone however led to an extended
inflammation which has been found to result in adhesion formation (50). It has not
been defined whether a predisposed location exist within ligament or tendon for
this process to occur (50).
Suture and ligament or suture and tendon interface have been found to be the
weakest link in initial surgical repair due to lack of implant stability and cyclic motion
(46,50). Studies, which have tested suture and ligament interface, have found that
braided suture was significantly more abrasive than monofilament and caused a
sawing effect during cyclical loading (51). This effect ultimately led to suture pulling
through the soft tissue and failure of the construct (51). This could be resolved,
increasing contact surface between the implant and tissue applying for example
more complicated suture knots. They appeared to be more stable as compared
with the simple knots, in a study which looked at differences between massive cut
(MAC) and modified Mason-Allen (MMA) sutures in rotator cuff repair (52).
Recent research has also introduced bio scaffold, porcine small intestine
submucosa (SIS), which had promising results in tissue healing (46). Further
proposed scaffold materials which had a positive influence on regeneration include
biodegradable metallic scaffolds, porous magnesium or magnesium oxide (46).
The aim of bio implants as well as bioactive agents is to enhance implant stability
within tissue which would ultimately enhance the healing.
Cartilage - and Soft Tissue - Bone Interface
Bone, cartilage and ligament are often found in such anatomic structures as
subchondral bone or ligament attachments. However, the relationship between
tissues is not only anatomical but also physiological. Cooperation between them
leads to a coordinated motion of the musculoskeletal system. Interaction between
their interfaces can be further explained by transmission of mechanical forces.
Cartilage is mostly suspected to compressive as well as shear stresses during joint
kinematics, which are absorbed by the tissue and further transmitted to trabecular
bone. Ligaments and tendons are mostly suspected to tension stresses during
physiologic joint motion and muscle contraction which is further absorbed by the
tissue and transmitted to bone.
The communication and similarities between cartilage and bone have been already
seen at the genetic level (54). Under in vitro conditions, osteoblasts are known to
stimulate chondrocytes differentiation (55). Furthermore, in patients with
osteoarthritis (OA) certain genes expressed by the osteoblasts harvested from
sclerotic areas of subchondral bone have been found to modulate functions of
chondrocytes (56). The genetic similarities between osteoblasts and chondrocytes
can be explained with a similar developmental pathway merged with a common
progenitor cell and confirm the communication theory between both tissues and
cell types (54).
6

As stated in paragraph above cartilage is defined as an avascular tissue which
receives nutrients and oxygen through synovial fluid and from vasculature present
in subchondral bone and calcified cartilage (54,57). Density of vasculature in
subchondral bone has been directly influenced by the loading conditions (58).
Further increase in vasculature density, protease expression, matrix degradation
and increase in bone deposition adjacent to vasculature have been observed in
bone with severe OA (59). Efficient transport across calcified cartilage from
subchondral bone was proven in a study which measured concentration of
hepatocyte growth factor within cartilage (60). In addition to vasculature, sensory
nerves have been observed in the vascular channels at osteochondral junction
which have been further associated with osteoarthritic pain in patients with OA
(59).
Ligament and bone interface is highly organized in a specific structure named
enthesis (61). Entheses connect tissues with different biomechanical profiles and
are therefore suspected to complex stresses (62). These include tensile stresses
applied to ligament and compressive stresses applied to bone (61). The complex
stresses within structures require from entheses to have a gradient in tissue
organization in order to effectively transmit forces across the interface and
maintain communication between cells with different phenotype (61). Gradient in
tissue organization relates to four transition zones, including ligament, nonmineralized fibrocartilage, mineralized fibrocartilage, and bone (61).
Differences between all four zones have been explained with the stress distribution
within enthesis. Tensile stresses are highest within ligament and gradually
decrease towards bone (63). Gradual increase in mineralization across the
interface is constant with gradual decrease in collagen fiber organization moving
from ligament to bone and results in a smooth mechanical stress distribution
(64,65). Furthermore, presence of hyaline cartilage between calcified tissue and
bone is associated with tissue adjustment to compression stress. In general, the
differences are associated with ECM content, predominant collagen type (I,II,III
and X) as well as cellular material (tenocytes, fibroblasts, fibrochondrocytes,
osteoblasts, osteoclast and osteocytes) (61).
Research in regenerative medicine and orthopedic surgery currently aims at
designing devices which could be used to surgically repair and reattach injured
soft tissue to bone, mimicking the sophisticated and complicated structure of
enthesis. Up to date however, such devices which would ideally mimic the enthesis
have not been designed yet and the surgical repair of enthesis results in a
mechanically inferior fibrovascular tissue formation at the repair site (66). Suture
anchors are currently the most commonly used surgical implants to reattach the
ligaments. The implants consist of two parts connected through an eyelet, the
anchor part which is buried in bone and the suture part which reattaches ligament.
The biomedical engineering has utilized a combination of micro- and nanointerfaces in designed devices to gradually distribute complex forces. Several
7

materials have been employed in the research including ceramics, natural
polymers (alginate, silk, collagen) and synthetic polymers [poly(ɛ-caprolactone)
(PCL), poly-L-lactic acid (PLLA), polyglycolic acid (PGA), and polylactid-coglycolid acid (PLGA)] (61). Similarly, on the ligament site, utilized materials include
natural (collagen, silk) and synthetic polymers [polyglycolic acid (PGA), poly-Llactic acid (PLLA)] as well as decellularized native tendon or ligament (61).
The target is to create hybrid materials with different mechanical properties to
optimally mimic gradient in enthesis mechanical properties (61). Specifically, using
a combination of polymer and ceramic with different Young’s modulus would better
mimic the gradual mineralization across enthesis (67). An example includes a
recent research done on complex and stratified collagen scaffold which
incorporated following materials, collagen, collagen cross-linked with chondroitin
sulfate and collagen mixed with HA (68). The stratified structure resulted in a
smooth stress distribution and distinct cells adhesion within the implant. Further
scaffolds are in shape of films, hydrogels, sponges or foam porous scaffolds,
meshes and micro/nanofibers.
The surface of an implant has been also modified with nanocomposites which
successfully increased scaffold porosity, surface area, and roughness resulting in
superior physicochemical properties, increased protein adsorption and nutrient
exchange (67,69). The bioactive agents such as mesenchymal stem cells (MSC),
tenocytes, dermal fibroblasts have been also used to improve implant stability
(61,66). Next, several growth factors have been used including transforming
growth factor-b (TGF-b), growth differentiation factor (GDF), platelet derived
growth factor (PDGF), fibroblast growth factor (FGF), and connective tissue growth
factor (CTGF) (61,66). Finally, proteins have been incorporated into the implants
including bone morphogenetic protein (BMP-2,-7), parathyroid hormone related
protein (PTHrP), Indian hedgehog (Ihh) as well as transcription factor (Sox9). All
above mentioned bioactive agents have been shown to increase cell proliferation
and protein expression as well as increased extracellular matrix (ECM) production
in soft tissues (70,66).
Surgical Implant and Bone Interface
Surgical implant and bone interface is very important for the construct stability.
Implants, such as orthopedic screw, plates and nails have been used in
orthopedics as well as in orthodontics to repair injured bone and ceramic tooth. If
bone insult is associated with a tissue loss, the defects are filled with either
autologous or allogeneic bone grafts, depending on the size of a defect and
preference of the surgeon. Injured bones, especially long, weight-bearing bones
with a compromised structure, are unable to mechanically withstand the loading
conditions. Therefore, surgical repair of long bones warrants additional mechanical
support and ultimately creates an environment which stimulates bone healing. In
orthodontics, the ceramic teeth are being implanted for esthetic reasons.
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Proper fixation can be only achieved with stable implants and literature defines
implant stability as primary (mechanical) and secondary (biological). Implant
stability has been widely studied in the literature and it has been found that the
micro-motion between bone and implant exceeding 150 µm will negatively
influence secondary stability (71-74). The excessive motion leads to increased
tensile and shear stresses which are associated with a fibrous membrane
formation around the implant, otherwise called fibroplasia (75,76). Fibroplasia can
further result in further implant displacement decreasing implants secondary
stability (75,76).
Implant integration within bone has been found to be dependent three properties
of the materials, including osteoinduction, osteoconduction and osseointegration
(71,77-80). Osteoinduction has been defined as ability of the material to stimulate
undifferantied and pluripotent cells to form the bone-forming cell lines (77).
Osteoconduction has been defined as material ability to allow for bone tissue
growth on the outer surface as well as within the pores and interconnected
channels (77-80). Both terms are difficult to differentiate under in-vivo conditions,
because injury created during implant placement or bone fracture begins cellular
and extracellular bone healing cascade which already contain osteoinductive
growth and differentiation factors (77,81,82).
Osseointegration has become one of the most important terms defining bone and
implant interface (71,77-80). This term has been widely studied in orthodontic
surgery as well as less frequently in orthopedics (80,83-88). The pioneers who
discovered the process are Brånemark et al, however Albrektsson et al evaluated
the process under light microscope and defined it as direct contact between bone
and implant (89,90). In order to say that an implant is well osseointegrated, direct
bone formation line around the implant has to be really thin and ranged between
10 and 20 µm (77). It can occur directly on the implant as direct osteogenesis or
from surrounding bone as distance osteogenesis (71). Osseointegration is strongly
associated with osteoinduction and osteoconduction (71,77). The biomechanical
definition of osseointegration describes it as a process which leads to rigid fixation
achievement of the alloplastic material which can be maintained during physiologic
loading (91).
Osseointegration process has been further distinguish in several biologic stages
which are corresponding to bone healing. Those include hematoma formation,
mesenchymal tissue development, intramembranous woven bone formation as
well as lamellar bone formation (72,92). First stage is initiated with internal
bleeding caused by implant insertion. Blood cells involving red blood cells, platelets
as well as inflammatory cells such as polymorphonuclear granulocytes and
monocytes reach the implant surface through extravascular migration (82).
Migrated cells are being entrapped on implants surface and activated there.
Activation is followed by secretion of cytokines and other growth factors, such as
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insulin like growth factor (IGF I and II), fibroblast growth factor (FGF), transforming
growth factors beta (TGF-β), and platelet derived growth factor (PDGF) (82). Bone
morphogenetic protein-2 and -7 that belong to TGF-β family have gained a special
interest in orthopedic research due to their excellent osteoinductive properties.
Activation of platelets induces several morphological and biochemical changes
which consist of adhesion, aggregation as well as induction of phosphotyrozine,
intracellular calcium increase, and phospholipids hydrolysis (82). Present cellular
material ultimately shapes a fibrin matrix which works as a biologic and
osteoconductive scaffold that also stimulates osteogenic cells to produce bone
around the implant (osteoinduction)(82).
Originally created matrix consist of poorly mineralized osteoid tissue structurally
similar to bone cement lines and laminae, which forms a continuous 0.5 mm thick
layer containing mainly calcium, phosphorus, osteopontin and bone sialoprotein
(92). This thin osteoid tissue layer is being gradually calcified by osteoblasts
directly on implants surface. Osteoblasts furthermore support this process by
collagen matrix deposition (92). Calcification process is followed by the vascular
and stem cells invasion in the non-calcified spaces (93). Vascularization is a vital
part of ostoegenesis which has a significant impact on osseointegration process
(94,95).
Direct and distance osteogenesis occurs simultaneously with host bone resorption
conducted by osteoclasts and the processes are separated with a clear
demarcation line. Early mineralized osteoid tissue is being gradually transformed
into a woven bone which not only is a space filler but also maintains integrity
between host tissue and implant providing a mechanical support during the early
loading phase (94,95). Three-dimensional woven bone works furthermore as a
scaffold for cell attachment and bone deposition (94,96). These early processes
related to bone formation begin as soon as 10-14 days after implantation (95).
Within three months after the surgery, woven bone is being gradually remodeled
into a lamellar bone (95). During the remodeling phase, new osteons circle around
the implant with long axis parallel to implants surface. Osseointegration of an
implant is confirmed with a thin line of bone containing osteoclasts, osteoblasts,
mesenchymal stem cells as well as lymphatic/blood vessels in immediate
surroundings. This line can further extend up to 1 mm away from implants surface
(77,96).
Factors Affecting Osseointegration
Osseointegration is a complicated process which has been found to be positively
influenced by several factors such as topography of implant surface, material,
shape, length, diameter, material surface treatment and coatings (hydroxyapatite,
bone morphogenetic protein-2) (97), status of adjacent bone (98), mechanical
stability and loading conditions applied to the implant (90), adjuvant treatments
10

such as bone grafting, osteogenic biological coatings (99-101) as well as
pharmacological agents such as simvastin and bisphosphonates (102,103).
Macroscopic and microscopic topography of the implant has a vital impact on
integration with adjacent bone. It has been proven that a rough surface of the
implant stimulates osseointegration through several known mechanisms. Rough
surface regulates osteoblast activation, proliferation and differentiation and these
processes have been associated with activation of integrin receptors that bind to
sequences/domains arginine-glycine-aspartate (ArgGly-ASP or RGD) of proteins
(104,105). These Arg-Gly-Asp or RGD are expressed in several bone matrix
proteins, including collagen I, fibronectin, osteopontin and bone sialoprotein. After
implantation they are immobilized on material surface to promote cell adhesion via
ligand receptor reaction (105,106). Activated integrins regulate phosphokinase C
and A through phospholipase C and A2 pathways (104).
Rough surface have been further associated with a higher expression of bone
formation indicators such as osteocalcin and alkaline phosphatase (101). It also
increases implant area in contact with host bone (BIC) supporting primary stability
(107,108). Several methods such as spraying with titanium plasma, coating with
hydroxyapatite, machine processing such as polishing, sandblasting and acid
etching have been described to increase roughness of the surface (108,109).
Smooth surface on the other hand induces more commonly distance osteogenesis
in contrast to rough surface (110). Optimal size of microscopic pores an implant
have been defined as 80 µm and above to enhance bone formation on implants
surface (111). Recent studies have further shown that utilizing multiple surface
topography such as a combination of micro and nano topography even more
enhances osseointegration process. Nano pores have a direct impact on selective
adhesion of osteoblasts and positively influence their proliferation and
differentiation (112). Interestingly, even small amount of micro motion (around 30
µm) has been associated with enhanced osseointegration, however any motion
above 150 µm significantly impairs the process (72-74).
Gap size between implant and bone also influences osseointegration process. If
an implant is placed in a tight contact with bone, only poor bone formation or even
bone resorption has been observed, whereas presence of a small gap between
implant body and host bone allows for a new trabeculae formation and therefore
supports biological fixation. Gaps should however not exceed 500 µm to not
reduce the quality of newly formed bone as well as to not delay gap filling process
(95,113). Increased gap size significantly reduces bone and implant contact
surface (BIC) which has been defined as significant parameter of osseointegration.
The process can be also evaluated with bone density measurements,
histomorphometry, mineral apposition rate as well as biomechanical tests such as
torque measurements, push-out or pullout tests, and resonance frequency test.
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The type of material has also a significant influence on osseointegration. To the
physical properties which are of importance in the process belong materials
modulus, ideally would be similar to cortical bone, high volumetric porosity (7080%), high frictional characteristics as well as excellent biocompatibility (114).
Recently discovered porous tantalum (c.p. tantalum) has been found to be
currently the best osseointegrative material (114). Another method to enhance
osseointegration, material coatings, such as hydroxyapatite coating which has
been also shown to significantly stimulate the process due to excellent
osteoconductive and osteoinductive properties.
The literature provides several factors that in contrast have a negative impact on
osseointegration process, and those include previously mentioned excessive
micro motion (above 150 µm) and related to it increased interfacial strain,
inappropriate porosity of the porous coating, radiation therapy (76, 114-116),
medications such as cyclosporine A, methotrexate, cis-platinum, warfarin, low
molecular weight heparins as well as non-steroidal anti-inflammatory drugs
(NSAID) (116-122). The most common nonselective COX-1 and COX-2 inhibitors
include diclofenac and phenylbutazone. Diclofenac delayed bone healing in
cortical and cancellous bone around titanium implants inserted in the rats after
continuous administration for 5 days (122). Phenylbutazone on the other hand
reduced the mineral apposition rate in horses after 14 days of continuous
administration (123).
Further negative for osseointegration factors include osteoporosis, rheumatoid
arthritis, advanced age, nutritional deficiency, smoking and renal insufficiency
(124-127). In osteoporosis, the balance between anabolic and catabolic bone
metabolism is impaired, causing increased activity of osteoclasts and reduced
neovascularization process (81). All of above-mentioned factors lead to failure of
peri-implant osteogenesis which has been associated with decreased number and
activity of osteogenic cells, increased osteoclastic activity, imbalance between
anabolic and catabolic local factors, abnormal bone cell proliferation rate as well
as impaired vascularization of peri-implant tissue (97). Osseointegration is a
dynamic process named otherwise as biological fixation because it occurs over
time after implant placement and it results in secondary stability of the implant.
Implant Stability in Bone
The bond between implant (orthopedic screw or dental implant) and bone is
defined with primary and secondary stability. Primary stability is obtained by the
implant immediately after placement in bone and it has been influenced by several
factors such as surgical technique, implant design, surface texture, loading and
related to it micro motion as well as quality of surrounding bone (128-131). Primary
stability has been also defined as “mechanical stability” because occurs
immediately after implant placement and it is not affected by the osseointegration
process (132). Furthermore, because primary stability is associated only with
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mechanical properties, it can be easily evaluated under in-vivo as well as ex-vivo
conditions.
One of the factors strongly correlated with primary stability is surgical technique
and especially insertional torque. Surgical drilling not only causes damage to
surrounding bone but also increases temperature within adjacent tissue (132).
Death of bone cells occurs when temperature exceeds 47 °C over a time of 1 min
(133). Furthermore, surgeons commonly undersize drilling osteotomy prior to
implant placement to increase insertion torque during implant placement and
increase primary stability. Several studies have found that better primary stability
is achieved when osteotomy is 10% smaller than the outside diameter of an
implant. Further decreasing the size of osteotomy to 25% of the outside diameter
has not given additional benefits (134).
A high insertional torque of dental implants has also been found to have a
destructive effect on direct peri-implant tissue causing micro fractures and
subsequent bone resorption (135-137). Orthodontic research recommends a lower
insertional torque because it is more osteoprotective, resulting in better
osseointegration over time (138-140).
Situation looks slightly different in orthopedics. Several articles in orthopedic
research have looked at the difference in primary stability of self-tapping and nonself-tapping screws. Self-tapping screws have been found to have a significantly
higher insertional torque and through that higher primary stability (128,141-143).
Higher insertion torque was attributed to torque required to cut the threads in bone
with a cutting flute at the top of implant (128,141). Non-self-tapping screws lack
this cutting flute and their placement is preceded with pre-tapping process which
is conducted using a tap device (128,141). The tap devices have longer threads
creating a micro gap between screw and bone, which results in a significantly lower
insertion torque but also in a micro motion and increased interfacial strain
(130,131,135,141). Micro gap decreases further the BIC and leads to a lower
primary stability of the implant (144).
Encountered discrepancies between the stability of an implant in orthodontics and
orthopedics can be explained with bone anatomy and implant design. The
craniofacial bones contain mostly cancellous bone which has lower bone mineral
density (BMD) in contrast to the long bones which due to a higher content of
cortical bone, have higher BMD (145,146). Lower BMD has been also associated
with lower BIC. Both have been strongly correlated with primary implant stability
and insertion torque (IT) (147,148). Because the craniofacial bones have lower
BMD, the peak IT is generally lower than in load bearing bones, and they are more
prone to the destructive effect of higher IT. Furthermore, increased IT does not
result in increased BIC and primary stability of the implants used in orthodontics.
In orthopedics denser bones are more resistant to the higher IT which results in
higher BIC and primary stability of the implant.
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Primary stability can be evaluated under in-vivo as well as ex-vivo conditions using
common mechanical testing methods such as resonance frequency analysis
(RFA), percussion test (Periotest), insertion torque (IT) and cutting torque
resistance analysis (CRA). Under Ex-vivo conditions followed methods can be
utilized including pullout, pushout and bending. Results of implant primary stability
measured with RFA under in-vivo conditions are displayed as implant stability
quotient (ISQ) which is a graphical (Figure 1) and numerical representation of
implant stability and related micro motion. ISQ ranges from 1 to 100, where 1 is a
mobile implant and 100 implies maximum stability. ISQ cutoff has been defined as
47 and below this value the implant has no sufficient primary stability (149,150).
As new bone is being formed around the implant, secondary stability is being
achieved (Figure 1, all figures are placed in the appendix) (85). Secondary stability
is related to long-term stability of the implant and bone interface and it is obtained
during the process of osseointegration (132,137). Secondary stability has been
named otherwise “biological stability” due to healing influence on the process
(132). Since both processes occur simultaneously, the same factors which impact
osseointegration, will have an impact on secondary stability (79,97-103).
Several studies have found a significant association between primary and
secondary stability (132,135,137). In other words, lesser micro motion leads to
better osseointegration. Recent systematic review reports a correlation between
primary and secondary stability measured with RFA to be significant and equaled
0.847 (137). Several other studies which looked at survival rate of dental implants
with or without primary stability have found that primary stability is not the only
factor influencing osseointegration (131,132).
The literature does not provide a specific definition of lack of primary stability. One
study classified lack of primary stability of the dental implants into four categories,
and those included no rotation [1], light rotation with a feeling of resistance [2],
rotation without resistance [3], and rotation combined with lateral oscillation [4]
(151). The implants which were assigned to second, third and fourth category were
defined as implants having no stability (151). Other research defined lack of
stability as a torque below 10 Ncm and slight lateral mobility (152).
Another recent study looked at 3111 dental implants and reported 79.8% survival
rate of the implants with no primary stability (71 out of 89) over 3 years compared
with 93.4% (2823 out of 3022) survival rate of the implants with primary stability
over 3 years (153). More detailed analysis of the without primary stability revealed
a significant difference in survival rate of implants coated (91.8%) and not coated
(53.6%) with Hydroxyapatite (HA) (153). This confirms relevance of texture of the
implant surface in osseointegration process as well as implies that HA coating may
improve osseointegration process even in the implants without primary stability.
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Rough surface as a beneficial effect in obtaining osseointegration similarly among
the implants with or without primary stability. The process can be evaluated with a
limited number of mechanical tests under in-vivo as well as ex-vivo conditions,
including resonance frequency analysis (RFA) or percussion test (Periotest).
Significantly more tests can be conducted to evaluate the process ex-vivo,
including peak reverse torque (PRT), pullout, pushout, torsion and bending test.
In-Vivo and Ex-Vivo Stability Testing
Mechanical testing of implant stability provides several options which can be
conducted under in-vivo as well as ex-vivo conditions (88,154-157). The tests
include resonance frequency analysis (RFA), percussion test (Periotest), insertion
torque (IT) as well as cutting torque resistance analysis (CRA). Those tests
evaluate implants micro motion as well as encountered resistance during
placement of the implant. The tests have been therefore used to evaluate primary
as well as secondary stability.
The method most commonly used in dentistry to evaluate primary and secondary
implant stability is resonance frequency analysis (RFA). It has been developed and
described by Meredith et al in 1998 (154). It utilizes an L shaped transducer device
connected with a vibrating element and receptor. The vibrating element applies a
continuous and repeatable impact wave or a single impact force to the assessed
implant and the receptor in device records resonance signal from the implant and
bone component (154,158). Originally, the resonance was measured in Hz unit,
but over time this was replaced by a new, developed by Osstell et al., ISQ unit
which corresponds with implant stability quotient (149,150).
Another test utilized in orthodontics to measure primary stability is Periotest. The
test was originally developed and described by Schulte et al. to evaluate natural
tooth mobility (155). The device contains a metallic rod that applies controlled
tapping force to the object. The response to tapping is measured by a sensor within
the hand piece and it is converted to periotest value (PTV). PTV ranges from -8
(low mobility) to +50 (high mobility) (88,155). The PTV values of an
osseointegrated implant fall in the range of -5 to +5 (88). The scientific articles
have assumed that PTV precisely reflects the BIC (156).
Cutting Torque Resistance Analysis (CRA) was developed by Friberg at all in 1995
(157). This method measures a torque required to cut a thread in the implant
osteotomy site during a low-speed threading. It gives a valuable information about
the quality of adjacent bone (157). CRA has been used significantly less frequently
than insertion torque (IT) measuring method. The methods described above are
used primarily in orthodontics and the research in orthopedics is lacking.
Insertion torque (IT) measures peak resistance torque during implant placement
(142,158,159). IT has been measured only during implant placement therefore it
does not assess development of osseointegration and secondary stability of the
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implant (142). It has been widely studied in orthodontics as well as in orthopedics.
Utilization of this method has developed recommendations regarding optimal
insertion torque during specific implant placement. For instance, the orthodontic
studies recommend optimal torque for implant placement of 0.032 Nm (159). The
IT values in orthopedics are significantly higher and dependent on the size of
placed screw within the orthopedic plate, e.g. 1.70 Nm for 3.5 mm screw or 4.0 Nm
for 4.5 mm screw (160,161). It is a feasible method which can be used to assess
primary stability of an implant under in-vivo as well as ex-vivo conditions.
Ex-Vivo Stability Testing
Hence secondary stability occurs over time, it can be only evaluated after the
implant had been placed in tissue. Based on above provided literature review,
osseointegration process occurs as early as 14 days after implantation and it may
take up to 3 months. There are several mechanical tests which can be utilized
under both in-vivo as well as ex-vivo conditions and most significant are described
in the paragraph above. Several other methods not only test the implant
integration, but also the integrity of entire construct repaired with the implant, can
be only conducted under ex-vivo conditions. Those methods require a mechanical
testing system such as Instron machine and include pullout, pushout, torsion and
bending tests. Peak reverse torque can be also performed using a torque
measuring screwdriver.
Peak reverse torque (PRT) has been successfully used in the research on
orthodontic as well as orthopedic implants (86,87,129-131,162,163). This method
measures torque required to remove an implant from bone and to break the bond
between bone and osseointegrated implant (86,87,129-131,162,163). PRT has
been shown to be strongly influenced by the grade of osseointegration (86,129131). It is a very sensitive method to evaluate not only a single orthodontic or
orthopedic implant but also the entire orthopedic plate-screw stability as it has
been recently proven (86).
Osseointegration has been negatively influenced by loading conditions and micro
motion of the implant as stated in the paragraph above. The differences in loading
between single implants used to fix dynamic compression (DC) orthopedic plate,
should affect the osseointegration process (86). Hence, the axial strength of a DC
plate can be predicted with axial strength of the weakest screw in the construct,
PRT provides more insight information about the stability of entire tested construct
(86).
Further mechanical testing methods discussed in this literature review are used to
test entire constructs such as a long bone repaired with orthopedic plate and
screws (128) as well as soft tissue constructs such as anchoring the thyroid
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cartilage with laryngeal clamps (164) or collateral ligaments with the suture
anchors (165). The tests have to be conducted under ex-vivo conditions because
their aim is to test construct stability until it fails (128,164,166-168). Pullout tests
have been used to test single implants or entire constructs in several orthopedic
as well as soft tissue studies (128,164,166-168). Pullout is caused by displacement
of the actuator in the testing frame which applies tensile stresses to tested implant
or entire construct (169). Tests are being conducted until implant is being entirely
removed from tissue and construct fails (164,166,167). Rate of displacement
should be adjusted accordingly to the testing method created for specific construct.
During tests several mechanical parameters are measured, and the most
important involve maximum tension load, actuator displacement and construct
stiffness. Maximum tension load has been defined as maximum tensile load
measured at implant or construct failure (170). The actuator displacement
corresponds with distance measured from its original position to its position at the
end of conducted study and construct stiffness corresponds with calculated load
over displacement slope (164,170).
A recent study used this method to evaluate stability of rostral laryngeal
advancement constructs (tie-forward), the surgery commonly performed on horses
suffering from dorsal displacement of soft palate (DDSP) (164). The method of
construct failure was associated with the suture and cartilage interface, due to
shear stresses applied by the suture to surrounding tissue. As a solution to this
problem a novel technology laryngeal clamp have been proposed (164). Laryngeal
clamps distribute tensile stress applied to them during swallowing, over a larger
area and therefore protect thyroid cartilage (164). The clamps increase stiffness of
entire construct, reducing the risk of construct displacement in postoperative
period (164).
Another test utilized to evaluate single implants or entire construct in bone as well
as soft tissue is torsional loading (169-172). In torsion, load applied to the
specimen causes its rotation about axis, previously specified in methodology (172).
Torsion creates a complex composition of internal stresses which involve
compression, tension and shear. Maximum values of all stresses have been found
on the surface of tested specimen and they are being reduced towards neutral
axis. Maximum shear stresses act on a plane perpendicular and parallel to neutral
axis, whereas maximum normal stresses (tensile and compressive) act 45° to the
axis of tested specimen. A recent study compared stability of an interference
screws versus unicortical buttons used to reattach the biceps tendon in human
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cadaveric model. The study utilized torsion method to assess the stability of both
implants with the conclusions that unicortical button provides a higher stability
fixation (172).
Bending tests have been widely used in biomechanical testing in orthopedic
research (166,173-175). The unique testing method also generates composition
of stresses which involve compression and tension (169,170). During bending,
compression stress is applied to upmost surface of the specimen, adjacent to the
actuator and tension is applied to opposite site, far from actuator (169,170). This
method has been used to test the entire constructs as opposed to single implant
(165,173-175). Current mechanical testing devices are capable of conducting two
different bending methods including 3- and 4-point bending.
The difference between 3- and 4-point bending is related to number of loading
points attached to actuator (175). In 3-point bending, the actuator contains one
loading point between two holding points, creating therefore three stressing points
on the tested specimen. Bending moment is concentrated in the area directly under
one loading point (175). This results in a higher focused bending stress. In
contrast, in 4-point bending, the actuator contains two loading points and two
holding points, therefore four stress points (165,173-175). Bending moment is
equally distributed between two loading points, increasing the distribution area of
bending stress (175). A recent study utilized 4-point bending method to evaluate
bending stiffness of metacarpophalangeal collateral ligament repair construct
which utilized suture anchors (165). The study compared the ultimate bending
resistance of native collateral ligaments and compared it to the constructs repaired
with the suture anchors. Further findings included no significant difference in
resistance to bending between constructs repaired with different suture anchors
(165). Conclusion of this study was that suture anchors can be used to enhance
immediate postoperative stabilization of injured collateral ligaments (165).
The literature review provides several options for mechanical testing of implant
stability. Methods can be utilized to test the bone or soft tissue constructs as well
as single implants. Depending on question stated in the research and implant of
interest, the method can be chosen and adjusted accordingly. All the tests can be
used in a simple load to failure mode or in cycles with relaxation and creep mode.
In some situations, cyclical tests mimic in-vivo conditions better than simple load
to failure.
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Conclusions
Surgical implantation leads to tissue injury and results in cellular death adjacent to
surgical site. Improved healing through enhanced cellular regeneration will
stimulate implant stabilization within tissue. Bleeding is the first step of healing in
all tissues described above and it has direct influence on the healing process.
Limited bleeding after tissue injury in avascular tissues such as cartilage and
ligament makes the integration process challenging. This literature review
provided several novel approaches on cartilage, ligament as well as in bone to
improve implant integration. Current knowledge reveals that design of implant,
close to native structure of targeted tissue has a better chance for integration. This
however cannot always be achieved, and, in such situations, bioactive coatings
may be a solution to stimulate the integration process.
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Figures

Figure 1-1. Implant stability in bone.
Graph presents gradual changes in primary (mechanical) vs secondary (biological)
stability of an implant placed in bone. Primary as well as secondary stability have
an influence on total implant stability. There is a decrease in total stability between
2 and 4 weeks after implantation. Graph imported from Raghavendra S, et al. Early
Wound Healing Around Endosseous Implants: A review of the Literature. The
International Journal of Oral & Maxillofacial Implants 2005; 20(3):425-430. The
permission to use the figure was granted by the publisher.
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Stable suture and cartilage interface is vital for implant integration and directly
influences the outcome of surgical procedures. Rostral laryngeal advancement
(tie-forward) is a very common procedure in horses that suffer under dorsal
displacement of the soft palate. This procedure relies on anchoring thyroid
cartilage to basihyoid bone and advancing entire larynx in the rostral and dorsal
direction. Suture implants aim to mimic the action of thyrohyoideus muscles which
have been proven to be dysfunctional in horses diagnosed with the disease.
Failure of the procedure has been further attributed to suture and thyroid cartilage
interface and more precisely to suture pulling through the cartilage. The conducted
study aimed to evaluate the stability of tie-forward constructs performed with
standard suture implants as well as suture implants stabilized with suture buttons.
Further objective embraced report of construct failure mode and comparison of the
biomechanical performance of the abovementioned techniques to novel design,
laryngeal clamps.
Abstract
Background
Rostral laryngeal advancement, also known as laryngeal tie-forward, is used to
treat horses for intermittent dorsal displacement of the soft palate and has a
morbidity rate of about 6%. We hypothesized that a novel laryngeal clamp would
prevent morbidity associated with the sutures tearing through the thyroid cartilage.
Larynges (n = 35 horses) were used for ex-vivo testing. For uniaxial testing, 15
equine larynges were tested in one of three laryngeal tie-forward constructs
[standard laryngeal tie-forward; modified laryngeal tie-forward using a suturebutton; and modified laryngeal tie-forward using a laryngeal clamp]. For biaxial
testing, 20 larynges were tested in one of two treatment groups: laryngeal tieforward and laryngeal tie-forward using a laryngeal clamp. Constructs were tested
in single cycle-to-failure. Statistical analyses were performed using ANOVA for
uniaxial testing and t-tests for biaxial testing.
Results
The laryngeal tie-forward using a laryngeal clamp construct was superior to
laryngeal tie-forward and laryngeal tie-forward using a suture-button constructs in
resistance to pullout in uniaxial testing. The laryngeal tie-forward using a laryngeal
clamp presented a significantly different method of failure than the standard
laryngeal tie-forward in the biaxial testing. Failure modes for each construct were
primarily by suture failure at the clamp (laryngeal tie-forward using a laryngeal
clamp), suture pullout through the thyroid cartilage, or, less commonly, tearing of
the cricothyroid ligament (laryngeal tie-forward). In uniaxial testing, the laryngeal
tie-forward using a laryngeal clamp failed most commonly due to tearing of the
cricothyroid ligament, whereas the standard laryngeal tie-forward and the
laryngeal tie-forward using a suture-button failed due to the tearing of the cartilage.
The laryngeal clamps provided greater stiffness, load at yield, and tensile stress at
yield than did the standard construct.
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Conclusions
Laryngeal clamps may offer an alternative to standard methods of anchoring the
thyroid cartilage when performing the laryngeal tie-forward procedure. Further
testing and clinical trials are needed to elucidate the utility of the laryngeal tieforward using a laryngeal clamp.
Introduction
Intermittent dorsal displacement of the soft palate (IDDSP) is a multifactorial
disease occurring in 10-20% of racehorses (1-7) and 28% of competing draft
horses (8). Females and young horses (2 - 4 years old) have been reported to be
more affected than male and older horses (9). The etiology of this disease is
multifactorial, and proposed causes include reduced activity of the thyrohyoideus
muscles (10-12), reduced activity of the palatine and palatopharyngeal muscles
(13), and reduced activity of the hypoglossal nerve (14).
The suggested medical and surgical treatments of affected horses are many,
because the pathophysiology associated with IDDSP is complex (15-22). Surgical
treatments include myectomy of the laryngeal retractor muscles (18-20),
staphylectomy (21,22), palatoplasty (21,22), and rostral advancement of the
larynx, commonly referred to as the laryngeal tie-forward (LTF) procedure (10-12).
The success rate of the LTF procedure in preventing IDDSP is reported to be in
the range of 80-82%, which is better than the rate associated with the other
procedures (11,12). This procedure advances the larynx dorsally and rostrally
using a biaxial suture construct in which two non-absorbable sutures, one inserted
through the caudoventral aspect of the right lamina of the thyroid cartilage and the
other inserted in a similar manner through the left lamina of the thyroid cartilage
and anchored to each other at the basihyoid bone, mimic the action of the
thyrohyoideus muscles (10,11). The incidence of complications associated with
this surgery has been reported to be about 6%, and the primary complication has
been the failure of one or both sutures to retain the larynx in its new position
(23,24).
The LTF procedure is most often performed using polyethylene or polyester
sutures (10,11,25,26), and according to previous reports, the procedure can fail if
one or both sutures break or tear through the thyroid cartilage. The LTF procedure
reported by Woodie et al. (2005) and Cheetham et al. (2008) has been modified
recently in an attempt to increase the mechanical strength of the construct
(5,11,26,27). Rossignol et al. (2012) modified the procedure by anchoring the
suture to the thyroid cartilage with metallic implants (i.e., "suture buttons"; LTFB),
which resulted in improvement of the mechanical stability of the construct during
mechanical testing (27). Rossignol et al. (2012) found, however, that the strength
of the modified LTFB construct was inferior to that of the standard LTF construct
and reported that the method of failure in both types of constructs was pullout of
the suture from the thyroid cartilage (25). An implant that reduces the risk of a
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pullout from the thyroid cartilage is needed, because the method of failure of the
LTF procedure in all tested constructs has been pullout of the construct through
the thyroid cartilage.
We hypothesized that a custom-designed, novel laryngeal clamp (LTFC) would
distribute tensile forces over a large area of the thyroid cartilage, thereby
eliminating morbidity associated with failure at the suture-cartilage interface. The
objectives of the study were to design and manufacture a novel laryngeal clamp
and to study the mechanical characteristics of the LTF constructs (LTF, LTFB,
LTFC) anchored to only one lamina of the thyroid cartilage (uniaxial testing) and
to mechanically test the strength of two different constructs (LTF, LTFC) anchored
to both laminae of the thyroid cartilage (biaxial testing). We expected that the
difference in ex-vivo uniaxial mechanical testing between the constructs would be
significantly different but testing between right-sided and left-sided constructs
would not be significant. We expected the results of ex-vivo mechanical testing
between the standard construct and the construct modified with clamps would be
significantly different in biaxial mechanical tests.
Materials and Methods
Preparation of the larynxes
Thirty-five larynges, each with its hyoid apparatus attached, were collected from
horses within 24 hours after the horses were euthanized for a reason unrelated to
the respiratory tract. Of these 35 larynges, 15 were used in proof-of-concept,
uniaxial mechanical studies, and 20 were used in biaxial mechanical studies.
Signalment data, including age, weight, breed, and sex, were available for horses
supplying the larynxes (n = 20) used for biaxial testing. Larynges were frozen at 20o C until mechanical testing was performed (25,27-32) and were thawed at room
temperature for 24 hours prior to testing. The larynges were wrapped in isotonic
saline-soaked gauze after they were thawed to keep them moist until tested.
Sample Measurements Collection
Before performing uniaxial tests, the thickness of the laminae of 15 thyroid
cartilages was measured at 3 locations, 10 mm apart, on the caudoventral margin
of the laminae, close to the insertion of the sternothyroideus muscles, using a
digital calipera. The thickness of the laminae of the 20 thyroid cartilages used for
biaxial testing was measured in a similar fashion but in 10 different locations on
each lamina to assess the properties of the thyroid cartilage (Figure 2-1, Table 21, all figures and tables are placed in the appendix). Locations 1 and 2 were at the
ventral and axial aspect of the thyroid cartilage. Locations 3 to 5 were at the dorsal
aspect of the thyroid cartilage, and locations 6 to 10 were at the caudoventral
aspect of the right and left laminae, close to the insertion of the sternothyroideus
muscle. Measurements were obtained to determine the space between the arms
of the U-shaped clamp necessary to insert the clamp onto the thyroid cartilage
(Figure 2-1).
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Uniaxial testing
Fifteen larynges were randomly assigned to one of three treatment groups
according to the construct tested, and each side of the larynx to which the construct
was applied was tested separately. Uniaxial tests on the suture-cartilage interface
included the following: 1) standard LTF using USP no. 5 polyester suture b, 2) LTF
modified with a suture button (LTFB), and 3) LTF modified with a custom-designed
laryngeal clamp (LTFC) (Figure 2-2). The uniaxial testing was performed to
evaluate the performance of a single implant anchored to the thyroid cartilage and
to assess the difference in the mechanical performance between the left and right
laminae of the thyroid cartilage.
Biaxial testing
Twenty larynges were randomly assigned to one of two treatment groups
according to the construct tested, and both sides of the larynx to which the
construct was applied were tested simultaneously. The constructs tested included
the LTF construct using USP no. 5 polyester suture b and the LTFC. The
ceratohyoid and thyrohyoid bones were removed from the basihyoid bone, which
was mounted on the loading frame of an electromechanical testing machine c. The
free ends of the sutures passing through the laminae of the thyroid cartilage were
attached to the basihyoid bone (Figure 2-3).
Laryngeal Tie-forward (LTF)
The LTF procedure was performed in a manner similar to the technique described
by Woodie et al. (2005) and Cheetham et al. (2008) (11, 12). Using this technique,
USP No. 5 polyester sutureb was inserted twice through the right or left lamina of
the thyroid cartilage, at the caudoventral aspect of the lamina, using a ½-circle,
trocar-point, needled to create a single loop around the caudoventral margin of the
lamina close to the tendon of insertion of the sternothyroideus muscle (Figure 23).
Laryngeal Tie-forward modified with suture buttons (LTFB)
The LTFB procedure was performed in a manner similar to the technique
described by Rossignol et al. (2012) (27). Using this technique, USP No. 5
polyester sutureb was threaded through the eyelet of the suture-button (2-mm thick
rounded plate with 2, 1.5-mm diameter holes), and the free ends of the sutures
were inserted through the eye of a ½-circle, trocar-point needled The needle was
passed once through the caudoventral margin of the right or left lamina of the
thyroid cartilage in a manner similar to that described using the LTF, and by
applying tension to the suture, the button became seated firmly on the ventral
aspect of the caudal edge of the thyroid cartilage (Figure 2-4).
Laryngeal Tie-forward modified with novel laryngeal clamp (LTFC)
The laryngeal clamps, composed of 316-stainless steel, were a broad U-shaped
device designed to wrap around the caudoventral border of the laminae of the
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thyroid cartilage. One arm of the clamp was 10 mm long, the other was 14 mm
long, and the gap with the “U” between the arms was 7 mm (Figure 2-5). The clamp
was inserted around the caudoventral border of the right or left lamina of the thyroid
cartilage close to the site of insertion of the sternothyroideus muscle, so the short
arm lay dorsal to the lamina and the long arm ventral to the lamina. The dorsal arm
contained two, 2-mm diameter holes spaced 2 mm apart, which together served
as an eyelet for the suture, and the ventral arm contained a slit through which the
suture was easily passed (Figure 2-5). The suture was attached to the clamp by
threading one end of the suture through one hole in the eyelet and the other end
through the adjacent hole, so the ends emerged between the arms of the clamp.
The ends of the suture were then threaded through the eye of a ½-circle, trocarpoint needled, which was passed once through the right or left lamina of the thyroid
cartilage close to the insertion of the sternothyroideus muscle. The needle
emerged approximately 5-10 mm rostral to the caudal margin of the lamina (Figure
2-6). The needle was removed, and the ends of the suture were passed through
the slit in the dorsal arm of the clamp. The clamp became seated firmly around the
caudal edge of the thyroid cartilage at the site of insertion of the sternothyroideus
muscle when tension was applied to the suture (Figure 2-6).
Uniaxial Biomechanical Testing
Laryngeal constructs were tested in a single cycle-to-failure test using an
electromechanical testing system with a 5-kN maximum load cellc. The larynges
were mounted to the machine as previously described (25). Briefly, a 3.2-cm
diameter cylinder of polyvinyl chloride (PVC) was passed into the lumen of the
larynx, and two 3.5-mm diameter, 40-cm long Steinmann pins were placed through
the larynx and cylinder perpendicular to the long axis of the cylinder and to each
other. One pin was placed through the cricoid cartilage, and a second pin through
the center of the thyroid cartilage, securing both cartilages firmly to the PVC
cylinder, avoiding interference with the cricothyroid ligament.
After mounting the cylinder and larynx on the loading frame of the
electromechanical testing machine with the rostral portion of the larynx uppermost,
(Figure 2-2), the ends of the suture were tied together around a 5-mm diameter
steel bar attached to a custom-made holding grip, with a surgeon’s knot, and
secured with 7 throws (Figure 2-2). The suture loop resided in the center of the
steel bar during the testing of each specimen, to mimic the direction of the suture
in-vivo and to maintain the repeatability of the testing conditions between the
specimens. The pullout tests were performed at a distraction rate of 300 mm/min
(25). The variables recorded for each construct included maximum load (N),
stiffness (N/mm), extension at maximum load (mm), extension at the break (mm),
extension at yield (mm), load at yield (N), tensile stress at yield (N/mm 2), and
tensile stress at maximum load (N/mm2). The maximum load was defined as the
maximum force loaded to the point of failure of any part of the construct, and the
stiffness was calculated from a load-displacement curve. Displacement was
defined as a change in distance between the thyroid cartilage and steel bar, and
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the tensile stress was defined as the force applied to the area of the thyroid
cartilage.
Three different modes of construct failure were observed and recorded, including
tearing of the thyroid cartilage, tearing of the cricothyroid ligament, and breaking
of the suture. The thyroid cartilage tore when the implant pulled through the
cartilage. The cricothyroid ligament tore when the implant caused the thyroid
cartilage to elevate and separate from the cricoid cartilage by tearing the
cricothyroid ligament, resulting in little or no damage to the thyroid cartilage.
Breaking of the suture, the third mode of failure, occurred at the knot of the loop
around the steel bar.
Biaxial Biomechanical Testing
The constructs tested in biaxial loading mimicked one of two clinical constructs,
LTF and LTFC. Both constructs were anchored and mounted on the Instron
machinec in the manner described above. After removing the hyoid apparatus, the
larynx was mounted on the upper loading cell of the electromechanical testing
machine. For the LTF construct, the free end of the ipsilateral dorsal arm of the
suture and contralateral ventral arm of the suture inserted through one lamina of
the thyroid cartilage were advanced rostrally and dorsally to the detached
basihyoid bone, which was mounted on the loading frame of the MTS testing
machinec. The same procedure was performed on the contralateral side. The
ventral arms of the right and left sutures were tied to each other around the ventral
aspect of the lingual process, with a surgeon's knot, and secured with 7 throws.
The dorsal arms of the right and left sutures were tied together in a similar fashion
(Figure 2-3).
To create the LTFC construct, both ends of each suture were advanced rostrally
and dorsally to the ipsilateral side of the basihyoid bone (Figure 2-3). The four arms
of the sutures were tied together around the ventral aspect of the lingual process
of the basihyoid bone, with a surgeon’s knot, and secured with 7 throws. The
pullout test was performed in a manner similar to that performed for uniaxial testing
at a distraction rate of 300 mm/min. Three different modes of construct failure were
observed and recorded and were the same as those observed during uniaxial
testing.
Statistical Analyses
Statistical analyses were performed by using IBM SPSS Statistics 25 e. Descriptive
statistics were calculated for all variables for all treatment groups and included
minimum, maximum, mean, and standard deviation. The normality of data
distribution for each variable was performed by using the Kolmogorov-Smirnov test
of normality.
The thickness of the 3 sites measured on laminae of the thyroid cartilage of the
larynges used for uniaxial testing was compared by using a two-tailed independent
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samples T-test. The thickness of the 10 sites measured on the right lamina of the
thyroid cartilage of the larynges used for biaxial testing was compared to the
thickness of the left lamina by using a two-tailed independent samples T-test. The
results were examined for homogeneity of variance, and each site was compared
by using ANOVA and the Tukey’s Post-hoc test. The thickness was also correlated
with the age, breed, and weight of donors by using a two-tailed Pearson
correlation.
For uniaxial tests, the differences in maximum load, stiffness, extension at
maximum load, extension at break, extension at yield, load at yield, tensile stress
at yield, and tensile stress at maximum load between the left and right testing side
of the thyroid cartilage were examined for homogeneity of variance. The
differences between each testing group were then analyzed by using ANOVA and
Tukey’s Post-hoc test. The correlation between the construct and method of failure
was examined by using Fisher’s exact tests.
For biaxial tests, the differences between two constructs were compared by using
a two-tailed independent samples T-test, and the correlation between the construct
and method of failure was tested by using the Fisher’s exact test. The level of
statistical significance was established at p < 0.05 and the power of the experiment
design and test combination was calculated using PS software f in the reference to
the results of maximum load during mechanical testing.
Results
Study Population
The weight of the horses from which the 35 larynges were harvested ranged from
450 to 650 kg (mean 570 ± 70.7 kg), and the ages of these horses ranged from 2
to 29 years old (mean 14.8 ± 8.1 years). Information about the breed and sex of
the donors was obtained only for the 20 larynges used in biaxial tests. The breeds
of these 20 horses included Thoroughbred (11), American Quarter Horse (3),
Tennessee walking horse (1), Warmblood (2), American Standardbred (1),
Hanoverian (1), and Clydesdale (1). Ten donors were female, and 10 were
geldings.
Sample Measurements Collection
The Kolmogorov-Smirnov test of normality of distribution showed the
measurements of cartilage thickness to be normally distributed in all tested
positions (p > 0.05). The Levene’s test for equality of variances revealed that equal
variances in all variables could be assumed (p > 0.05). The descriptive statistics
of the thickness measurements of the thyroid cartilage of the 15 larynges used in
the single-side testing (i.e., uniaxial tests) revealed that the mean thickness of the
caudoventral edge of the left thyroid cartilage lamina was 4.58 ± 0.7 mm. The mean
thickness of the caudoventral edge of the right thyroid cartilage lamina was 4.70 ±
0.7 mm (Table 2-3). The measurements of the caudoventral edge of the thyroid
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cartilage of the 10 larynges used in biaxial testing revealed that the mean thickness
of the caudoventral edge of the left thyroid cartilage lamina was 4.48 ± 1.3 mm.
The mean thickness of the caudoventral edge of the right thyroid cartilage lamina
was 4.50 ± 1.2 mm. The differences in the average thickness between the left and
right laminae of the thyroid cartilage in the study population were not statistically
significant (p > 0.05) (Tables 2-2 and 2-3).
Significant differences were found in the thickness of the laminae of the thyroid
cartilage among the different anatomical positions (p < 0.05). The position
numbers 7 (L – 6.01 ± 1.2 mm; R – 5.89 ± 1.2 mm), 8 (L – 4.95 ± 0.8 mm; R – 4.99
± 0.8 mm), and 10 (L – 6.47 ± 1.4 mm; R – 6.18 ± 1.6 mm) were significantly thicker
than the rest of the anatomical positions (p < 0.05) (Table 2-1). These sites were
at the caudal margin of the thyroid cartilage at the site of insertion of each
sternothyroideus muscle (Figure 2-1). No significant correlation was found
between the mean thickness of the caudoventral aspect of the margin of the
laminae of the thyroid cartilage and the age and breed of the donors for any sites
examined (p > 0.05). There was, however, a significant positive correlation
between the mean thickness of the laminae and the weight of the donors (r = 0.78,
p < 0.05)
Uniaxial Biomechanical Testing
Data was normally distributed and homogeneous for all variables (p > 0.05). The
two-tailed independent samples T-test did not reveal significant differences in the
results of biomechanical testing between the left and right side of the lamina (p >
0.05) (Table 2-3). The yield on the load-displacement curve corresponded to the
tearing of the thyroid cartilage (n = 22) or to the tearing of the cricothyroid ligament
(n = 7).
Uniaxial testing of the constructs revealed that the mean pullout strengths of the
LTFC (207 ± 43 N) and LTF (199 ± 19 N) constructs were significantly greater than
the mean pullout strength of the LTFB construct (176 ± 43 N) (p<0.05) and that the
difference in the mean pullout strength of the LTFC construct did not differ
significantly from that of the LTF constructs (p>0.05). Similarly, the mean load at
yield point was significantly greater for the LTFC (161 ± 45 N) and LTF (168 ± 23
N) constructs than that for the LTFB construct (139 ± 51 N) (p<0.05), but the mean
load at yield point for the LTFC construct did not differ significantly from that the of
the LTF construct. The results of the rest of the uniaxial mechanical testing were
not significantly different between the treatment groups (p>0.05) (Table 2-4, Figure
2-8).
Fisher’s exact test revealed a significant correlation between the construct and
method of failure (p < 0.05). Of the constructs modified with a laryngeal clamp,
70% failed by tearing the cricothyroid ligament, and 30% failed by tearing the
thyroid cartilage adjacent to the clamp. None of these constructs failed from the
break of the suture. All (100%) of the LTF constructs failed from tearing the thyroid
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cartilage. Constructs modified with a suture button failed from tearing the thyroid
cartilage (90%) or from breaking of the suture (10%).
Biaxial Biomechanical Testing
All variables, including biomechanical values, were normally distributed (p > 0.05).
Tests for equality of variances revealed that equal variances in all variables could
be assumed (p > 0.05).
As occurred in the uniaxial testing, the yield on the load-displacement curve
corresponded to tearing of the thyroid cartilage (n = 8) or to tearing of the
cricothyroid ligament (n = 3). The LTF construct compared to the LTFC in the
biaxial testing had a significantly higher mean maximum load (430.3 ± 64.84 N and
367.9 ± 55N respectively), lower mean extension at yield (33.38 ± 8.9 mm and
42.54 ± 7.81 mm respectively), higher mean extension at maximum load (64.9 ±
9.5 mm and 52.4 ± 8.4 mm respectively), higher mean extension at failure (65.4 ±
9.5 mm and 52.6 ± 8.5mm respectively), higher mean extension at maximum load
(64.9 ± 9.5 mm and 52.4 ±8.4 mm respectively) and higher mean tensile stress at
maximum load (43.13 ± 6.87 N/mm2 and 36.8 ± 9.1 N/mm2) (p<0.05) (Table 2-5).
The results of the rest of the biaxial mechanical testing were not significantly
different between the treatment groups (p>0.05) (Table 2-5, Figure 2-9).
There was a significant correlation between the construct and method of failure (p
< 0.05). Of constructs modified with clamps, 80% failed because the suture broke,
and 20% failed because the cricothyroid ligament tore (Figure 2-7). Standard LTF
constructs failed because the thyroid cartilage tore (80%) or because the
cricothyroid ligament tore (20%).
Discussion
The mode of failure of the construct modified with laryngeal clamps differed from
the mode of failure of the LTF construct. The mode of failure of the constructs
correlated with the type of implant used, regardless of whether one side of the
larynx or both sides of the larynx were tested. The LTF construct and the LTFB
construct failed in uniaxial testing most commonly by pulling of the implant through
the thyroid cartilage. Less commonly, the construct failed when the cricothyroid
ligament tore. The LTF construct failed in biaxial testing when the suture pulled
through the thyroid cartilage. The construct with the laryngeal clamps failed in
uniaxial testing when the thyroid cartilage elevated and separated from the cricoid
cartilage at the cricothyroid ligament. All constructs with the laryngeal clamps failed
in biaxial testing when the suture broke close to one of the laryngeal clamps. The
laryngeal clamps, therefore, protected the thyroid cartilage from tearing during
uniaxial and biaxial testing.
The mode of failure of the biaxial construct modified with clamps may have
perhaps been different, and the pullout force higher, if polyethylene suture, rather
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than polyester suture, had been used. Polyethylene suture has been shown to
provide greater resistance to fraying, higher tensile strength, and more elasticity
than the polyester suture used in both trials in our study (26,33). Although
polyethylene sutures performed better than polyester sutures in another similar
study, the difference in the performance of the entire construct was not statistically
significant, because the failure of the construct was due to failure of the thyroid
cartilage, rather than a failure of the suture (25). A study examining the mechanical
properties of various suture materials found polyethylene sutures to have a 500fold greater resistance to fraying than polyester sutures (33). This makes
polyethylene sutures particularly advantageous for attaching to metallic anchors or
to absorbable anchor eyelets (32). Comparing the mechanical performance of
various types of sutures used with the laryngeal clamp was beyond the scope of
this study.
The force required to disrupt the LTFC constructs was similar to that of the LTF
and LTFB constructs in uniaxial mechanical testing. The differences in the
properties of biological samples, including a difference in viscoelasticity, may
explain the high variability of force required to disrupt the constructs within each
group. In biaxial construct testing, however, the pullout force for the LTF constructs
was greater than the pullout force for the LTFC constructs. The LTFB construct
was not included in biaxial testing because it performed more poorly in the singleside testing than the LTF construct. In a recent biomechanical study, LTF
constructs had a higher pullout force in biaxial testing than did constructs modified
with suture buttons, regardless of whether the suture was polyethylene or polyester
(25).
The types of constructs failed at different forces and displacement at yield,
because of the different modes at which they failed. The yield point in the
mechanical testing corresponded with the force and displacement at which the
cartilage or the cricothyroid ligament started to fail. Interestingly, the extension at
which the construct failed differed distinctly among the types of constructs. The
force and displacement at yield was highest for the LTF construct in the uniaxial
testing followed next by the LTFC construct and then by the LTFB construct. The
load at yield was higher for the LTFC construct than for the LTF construct in the
biaxial testing. The higher load at yield resulted in a greater displacement at yield
for the LTFC construct than for the LTF construct but not significantly so. The yield
point of the LTFC constructs was rarely observed, because the entire construct
moved in the Instron machine until the suture failed, whereas the yield point of the
LTF construct was easily observed, because the suture, rather than the entire
construct, moved until the yield point of the construct was reached, which was that
point at which the thyroid cartilage began to tear.
The lower tensile force required to tear the cartilage in the LTF construct was
related to the higher shear stress applied directly to the thyroid cartilage by the
suture. The laryngeal clamp reduced stress by distributing the tensile force over a
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larger area of the thyroid cartilage. Yield points have not been reported in previous
mechanical studies examining LTF constructs (25-27). The study performed by
Santos et al. (2014) examined the force at 20- and 30-mm extensions (25). We
found the yield point to be about 34 mm for the LTF construct and about 42 mm
for the LTFC construct, but the wide standard deviation for the LTFC construct
suggests that the yield point was not constant for all tested constructs.
The stiffness of the LTFB construct was higher than that of the LTF and LTFC
constructs in the single-side testing, causing the LTFB to construct to have the
shortest extension when the suture broke. The LTF and LTFC constructs had a
similar extension at failure in the uniaxial testing. The extension at failure for the
LTFB construct, however, was higher than that reported by Santos et al. (2015),
though the trend in their study was similar (25). The LTFC constructs were stiffer
than the LTF constructs in biaxial testing, resulting in a lower extension when the
suture broke. The results of our tests showed that the LTFC constructs were stiffer
than the LTF constructs in the single-side testing and the biaxial testing, and
therefore, more force was required to disrupt the construct modified with clamps.
The higher stiffness of the LTF constructs modified with the laryngeal clamps is
likely to be associated with less laryngeal displacement under in-vivo conditions.
Clinical failure of the LTF construct is reported to occur most commonly during
recovery from general anesthesia when the horse rapidly and forcefully extends
its head (25). In our study, the constructs modified with the laryngeal clamps had
a pullout force of approximately 5.5 times that estimated to occur during maximal
head extension (25). The tensile stress at maximum load was significantly lower
for the LTFC construct than for the LTF construct, but the tensile stress at yield
was higher for the LTFC constructs than for the LTF constructs. This may suggest
that the tensile strength of the LTFC construct was greater at the moment when
the cartilage or cricothyroid ligament began to fail. In the majority of the LTFC
constructs, the suture, rather than the cartilage or the ligament, failed, resulting in
a short yield phase just before failure. The tensile stress applied to the constructs
under in-vivo conditions is not known, and therefore, the minimal stress the
constructs must withstand is not known.
The focus of this study was to evaluate the biomechanical performance of the LTF
construct modified with a novel laryngeal clamp and to compare it to currently used
constructs. One of the concerns with the novel design of the laryngeal clamps is
the tension applied to the sutures, which results in shear stress between the
sutures and metallic clamps during cyclical loading. The design tried to address
these concerns and apply modifications aimed at reducing the shear stress
between the suture and implant. Future research should examine additional
modifications to reduce the shear stress on the suture to improve the performance
of the LTFC construct. Also, the use of different sutures, such as polyethylene
sutures, to anchor the clamps should be examined. The limitation of this study was
the underpowered (β<0.8) design and test combination to detect hypothetical
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differences in mechanical properties between the constructs. Accounting for the
difference in the mean values of maximum loads between the constructs and the
standard deviations within the treatment groups, the study would necessitate 237
samples per treatment group to achieve study power β>0.8. Furthermore, this is
an ex-vivo study in which each of the larynges had to undergo one freeze-thaw
cycle which could have influenced the mechanical performance of the thyroid
cartilage or the cricothyroid ligament. The results of this study might differ from the
physiologic conditions and should be therefore interpreted with caution.
Conclusions
The prototype of the laryngeal clamp may offer an alternative to suture anchoring
in the thyroid cartilage in LTF constructs. The unique design of the laryngeal clamp
protected the cartilage by reducing the shear stress of the suture applied to the
cartilage, which resulted in the higher force and tensile strength at the failure of the
cartilage or ligament. This was associated with the increase in stiffness of the
construct. Increasing the stiffness of the construct could result in the lower
displacement of the construct over time in-vivo. The increased stiffness of the
construct modified with the clamps resulted in the sutures failing at lower maximum
force and displacement.
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Tables

Table 2-1. Measurements of larynx thickness.

Thickness measurements (mm)
Position

Mean

Std. Deviation

1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00

3.8872
3.9444
3.9336
3.5096
3.7696
3.9156
6.0163
4.9548
4.4984
6.4740

.84690
.76652
.72256
.56269
.60627
.67555
1.22410
.81034
.67038
1.43194
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Table 2-2. Thickness comparison between laminae of thyroid cartilage.

2-tailed independent samples T-test between left and right thyroid
cartilage
Measurement
Position_1
Position_2
Position_3
Position_4
Position_5
Position_6
Position_7
Position_8
Position_9
Position_10

Side

Mean

Std. Deviation

Sig. (2-tailed)

L
R
L
R
L
R
L
R
L
R
L
R
L
R
L
R
L
R
L
R

3.8872
4.1456
3.9444
3.7652
3.9336
4.0536
3.5096
3.6696
3.7696
3.7496
3.9156
3.9692
6.0163
5.8872
4.9548
4.9972
4.4984
4.6244
6.4740
6.1808

.84690
.81930
.76652
.63383
.72256
.73439
.56269
.59214
.60627
.64440
.67555
.74584
1.22410
1.23921
.81034
.82942
.67038
.75340
1.43194
1.57979

.278
.278
.372
.372
.563
.563
.332
.332
.910
.910
.791
.791
.716
.716
.856
.856
.535
.535
.495
.495

Comparison of thickness between the left and right laminae of the thyroid cartilage.
There were no significant differences between the left and right laminae at any of
the measured positions.
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Table 2-3. Side comparison in uniaxial testing.

2-tailed independent samples T-test between left and right thyroid
cartilage
Variable
Average Thickness
Maximum Load (N)
Stiffness (N/mm)
Extension at Failure
(mm)
Extension at Max Load
(mm)
Extension at Yield
(mm)
Load at Yield (N)
Tensile Stress at Yield
(N/mm2)
Tensile Stress at Max
Load (N/mm2)

Side

Mean

L
R
L
R
L
R
L
R
L
R
L
R
L
R
L
R
L
R

4.5833
4.6987
190.4900
197.6793
4.0580
4.1240
56.1173
52.9907
55.7880
51.1160
38.8507
41.1693
151.7260
159.9007
15.1747
15.9900
18.8954
19.7723

Std.
Deviation
.73626
.73201
34.96656
41.82675
1.40277
1.03332
17.44167
17.37226
17.60501
16.65160
14.03225
12.53842
45.32798
39.84170
4.53286
3.98632
3.20007
3.86754

Sig. (2tailed)
.670
.614
.884
.627
.461
.637
.604
.605
.535

Comparison of average biomechanical results obtained during uniaxial testing
involving the left or right laminae of the thyroid cartilage (2-tailed independent
samples T-test). The data obtained from the left side of the larynges did not differ
significantly from that obtained from the right side of the larynges.
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Table 2-4. Comparison of biomechanical results during uniaxial testing.

ANOVA of three different constructs
Variable Construct
Mean
Std. Deviation
Maximum Load (N)

Stiffness (N/mm)

Extension at
Failure (mm)
Extension at Max
Load (mm)
Extension at Yield
(mm)
Load at Yield (N)

Tensile Stress at
Yield (N/mm2)
Tensile Stress at
Max Load (N/mm2)

LTF
LTFB
LTFC
LTF
LTFB
LTFC
LTF
LTFB
LTFC
LTF
LTFB
LTFC
LTF
LTFB
LTFC
LTF
LTFB
LTFC
LTF
LTFB
LTFC
LTF
LTFB
LTFC

199.0180
176.3040
206.9320
3.8600
4.7650
3.6480
55.6220
46.2630
61.7770
53.0860
45.9100
61.3600
46.0220
29.2360
44.7720
167.5140
138.5570
161.3690
16.7520
13.8570
16.1380
19.8430
18.1510
20.4567

19.27660
43.18806
43.21904
.93406
1.36203
1.10265
12.66911
14.58875
21.02075
11.89288
14.71806
20.99364
12.83827
8.72437
10.95712
23.34335
51.10873
45.24054
2.33487
5.11180
4.52568
1.86375
4.24579
4.23621

Sig.
.024

.177

.087

.125

.125

.003

.278

.279

This table shows the mean values and standard deviations of the results of
biomechanical testing of 3 constructs. The results differed significantly in maximum
load (N) and load at yield (N) between the LTFC, LTF and LTFB constructs.
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Table 2-5. Comparison of biomechanical results during construct testing.

2-tailed independent samples T-test between two constructs
Variable
Average Thickness
(mm)
Maximum Load (N)
Extension at Failure
(mm)
Extension at Max
Load (mm)
Extension at Yield
(mm)
Load at Yield (N)
Tensile Stress at
Max Load (N/mm2)
Tensile Stress at
Yield (N/mm2)
Stiffness (N/mm)

Construct

Mean

LTF
LTFC
LTF
LTFC
LTF
LTFC
LTF
LTFC
LTF
LTFC
LTF
LTFC
LTF
LTFC
LTF
LTFC
LTF
LTFC

4.6010
4.7880
430.2940
367.8790
65.3910
52.5820
64.8970
52.4210
33.3780
42.5410
264.6490
306.2130
43.1300
36.8210
26.4660
30.6210
6.7250
7.0420

Std.
Deviation
.33834
.79014
64.84309
55.19138
9.47112
8.49355
9.52261
8.44992
8.98399
7.81333
65.42587
91.09641
6.86934
9.10953
6.54315
5.51279
1.12806
1.78153

Sig. (2tailed)
.500
.032
.005
.006
.026
.257
.040
.257
.640

The LTFC construct was inferior to the LTF construct in maximum load (p < 0.05),
extension at failure (p < 0.05), extension at maximum load (p < 0.05), and tensile
stress at maximum load (p < 0.05). The LTFC construct showed, however, a
superior trend compared to the LTF construct in extension at yield (p < 0.05). The
difference between the constructs in the remaining results were not significant
(p>0.05).
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Figures

Figure 2-1. Thickness at 10 different anatomical positions.
The thickest portion of the thyroid cartilage was found in positions 7-10, at the
attachment of previously removed sternothyroideus muscle.
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Figure 2-2. Single-side LTF mechanical testing.
This figure presents the experimental arrangement of a larynx in the MTS testing
machine. The larynx was attached to the 3.2-cm PVC cylinder, which was attached
to the holding grip of the MTS machine. A custom-made holding grip with a
stainless-steel bar was attached to the loading cell. Each larynx was in the same
treatment group, but each side of the construct was tested separately. The ends
of the suture were tightened and tied around the stainless-steel bar.
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Figure 2-3. Biomechanical constructs testing.
This figure shows the arrangement of the LTF and LTFC constructs in the MTS
machine. Larynges were mounted on a PVC cylinder, as in the single-side testing,
and the basihyoid bone was attached to the holding grip of the loading cell. In the
standard LTF construct, on the left side, the free ends of the ipsilateral dorsal
suture and contralateral ventral suture were advanced rostrally and dorsally to the
basihyoid bone. The same procedure was performed on the right side. The ventral
and dorsal sutures were tightened and tied together around the ventral aspect of
the lingual process of the basihyoid bone. In the LTF construct modified with the
laryngeal clamps, both ends of the sutures were advanced rostrally and dorsal to
the bone and tied together around the ventral aspect of the lingual process.
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Figure 2-4. Suture Button.
The commercially available suture button used for this study was a part of the kit
for the human cruciate ligament repair. The surgical technique used to anchor the
thyroid cartilage was performed as described by Rossignol et al. (2012)
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Figure 2-5. Views on laryngeal clamps.
The design of laryngeal clamps aimed at creating an anchor that wrapped around
the caudal border of the thyroid cartilage to distribute the tensile forces applied to
the suture. The laryngeal clamps were U-shaped, 5 mm wide, and 1cm long. The
short arm was placed on the dorsal surface of the thyroid cartilage, and the long
arm was placed on the ventral surface of the cartilage. The part connecting the
bottom and top parts was responsible for distributing the tensile force. The short,
dorsal arm had two holes, creating an eyelet for the suture, and the longer ventral
arm had a slit, though which suture could easily be passed.
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Figure 2-6. Laryngeal clamps on the thyroid cartilage.
The figure shows the arrangement of the laryngeal clamp around the caudoventral
border of the thyroid cartilage. The dorsal arm had an eyelet with the relief between
two holes, through which the suture was threaded before the clamp was placed.
The ends of the suture were threaded through the eye of a ½-circle needle, which
was passed through the caudal margin of the thyroid cartilage. After the needle
was passed, the ends of the suture were threaded through the slit on the dorsal
arm of the clamp. Tension applied to the suture caused the clamp to engage the
caudal margin of the lamina of the thyroid cartilage. The suture of this construct
had no dorsal and ventral arms, because both arms were inserted through the one
hole in the lamina of the thyroid cartilage.
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Figure 2-7. Before and after constructs testing.
The image on the left shows the construct before the testing, and the image on the
right shows the construct after the testing. The left and right laminae of the thyroid
cartilage are labeled. Notice that the appearance of the thyroid cartilage on the
right looks similar the appearance of the thyroid cartilage before the test. In this
case, the right laryngeal clamp pulled out from the thyroid cartilage without
inducing severe disruption of the crico-thyroid ligament and alteration of the
geometry of the thyroid cartilage.
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Figure 2-8. Comparison of biomechanical performance of uniaxial
constructs.
The uniaxial LTFC construct (gray line) attained the highest maximum load
followed first by the LTF and then LTFB construct. The method of failure
associated with LTFC construct was tearing of the cricothyroid ligament, whereas
the LTF and LTFB constructs failed because the thyroid cartilage tore. The LTFC
construct protected the cartilage.
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Figure 2-9. Comparison of biomechanical performance of the constructs.
The yield point of the LTF construct corresponded to the moment at which the
construct started to tear the thyroid cartilage. The first peak in this graph represents
tearing of the thyroid cartilage, and the second peak represents tearing of the
cricothyroid ligament. The LTFC construct failed when the suture failed its
attachment to the laryngeal clamp; no damage to thyroid cartilage was noticed at
the point of failure. The laryngeal clamp provided higher stiffness, force, and tensile
stress at yield point and a different method of failure, which was significantly
associated with the suture breaking.
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Abbreviations
IDDSP – Intermittent Displacement of the Soft Palate
LTF – Laryngeal Tie-forward
LTFB – Laryngeal Tie-forward modified with suture buttons
LTFC – Laryngeal Tie-forward modified with laryngeal clamps
PVC – Polyvinyl Chloride
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Footnotes
a.
b.
c.
d.
e.
f.

Husky Digital Caliper, The Home Depot, Atlanta, GA
Covidien, 710 Medtronic Parkway, Minneapolis, MN
Instron 5900, Instron, Norwood, MA
Richard-Allan, cat. no. 217001, Aspen Surgical, Caledonia, MI
SPSS ver. 25, IBM, 1 New Orchard Road Armonk, NY
PS Power and Sample Size Calculations ver 3.0, Vanderbilt University,
Department of Biostatistics
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CHAPTER THREE
BIOMECHANICAL EVALUATION OF PEAK REVERSE TORQUE
(PRT) IN A DYNAMIC COMPRESSION PLATE - SCREW
CONSTRUCT USED IN A GOAT TIBIA SEGMENTAL DEFECT
MODEL
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The strength of the bone and implant interface has been significantly correlated
with the primary and secondary stability of the implant. Primary stability is achieved
by the implant immediately after placement and it leads ultimately to secondary
stability, through the osseointegration process. Osseointegration has been found
to be influenced by several factors, from which the most important are loading
conditions applied to the implant and associated micromotion. The loading
stresses are not evenly distributed between the screws placed in orthopedic plate
and plate axial stability has been attributed to the stability of the weakest screw.
The purpose of the conducted in-vivo study was to evaluate the osseointegration
of the screws placed in dynamic compression plate (DCP) in tibial segmental
defects in goats. Further objective included the comparison of osseointegration
between the non-self-tapping and self-tapping screws after 60 days of in-vivo
loading.
Abstract
Background
Peak reverse torque (PRT) is a valid method to evaluate implants’ secondary
stability in the healing bone. The secondary stability is achieved by the implant
over time and it has been positively correlated with the implants’ osseointegration
level. In other words, peak reverse torque is the force required to break the boneimplant interface. The purpose of this study was to compare the peak reverse
torque for the self-tapping and non-self-tapping screws used in a dynamic
compression plate–screw–bone construct after 60 days of loading when used to
stabilize 2.5-cm defects in the tibia of goats. The second objective was to compare
the peak removal torque of the screws placed in the different positions to evaluate
the impact of construct biomechanics on implants osseointegration.
Results
In total, 176 non-self-tapping screws and 66 self-tapping screws were used to fix
the 8-holes dynamic compression plates to the bones. The screws were placed in
the tibiae from proximal (position sites 1,2, 3) to distal (position sites 4,5,6) and
were removed 60 days post-implantation. The goats remained weight-bearing
throughout the study period. The screws placed in the proximal diaphysis had
significantly less peak reverse torque than screws placed in the distal diaphysis in
both groups (p < 0.05). The peak reverse torque resistance was also significantly
less for the non-self-tapping screws as compared with the self-tapping screws (p
< 0.05). The intracortical fractures in the trans-cortex occurred significantly more
frequently during the placement of non-self-tapping screws (p < 0.05) as compared
with self-tapping screws (p < 0.05).
Conclusions
Based on these results, we concluded that self-tapping screws may be expected
to maintain a more stable bone-implant interface during the first 60 days of loading
as compared with non-self-tapping screws. This should be a consideration for
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orthopedic surgeons and scientists using bone plates to stabilize non-load sharing
fractures when a stable plate-screw-bone interface is needed to ensure prolonged
stability.
Introduction
Maintenance of the interface between screws and bone is important to ensure
adequate stabilization of fractures and to maintain mechanical support for the
healing tissue (1,2). The screw is a critical linkage to secure bone plates to bone.
Assuming that, the plate is sufficiently stiff and resilient under cyclical loading
conditions, and then the integrity of the screw-bone interface determines the
overall stability of the construct. The bone-screw interface is defined by its primary
and secondary stability. Primary stability is obtained by the screw immediately after
placing it into the bone and has been associated with several factors: surgical
technique, implant design, surface properties, loading, and quality of the bone (1,36). Secondary stability refers to the long-term stability of the screw-bone interface
and is directly related to the osseointegration between the bone and the implant’s
surface (3,7). Several factors have been described to be of importance in this
process: biocompatibility, surface texture, surgical technique, the status of the host
tissue, and loading conditions (3,7). Secondary stability can be measured using
resonance frequency (RF) or peak reverse torque (PRT) (3,8). Several studies,
mostly on orthodontic implants, have used PRT (3-7,9-15) showing that peak
reverse torque has been positively correlated with the osseointegration process
(3,5-6,13-16) and bone density (3,6,11,14).
Various fixation techniques have been described and used to stabilize tibia defects
using large animal models (17-21). These techniques include a single dynamic
compression plate fixation (17-19), locking intramedullary nail (20), and double
plate fixation (21) resulting in the different mechanical environments for the
regenerating bone. The studies that have used a single DCP concluded that this
fixation technique provides adequate stabilization for most large animal tibia defect
models (17-19).
Dynamic Compression Plate (DCP) is a type of conventional plate commonly used
in the fracture repairs (22). The plate mechanics rely on a transfer of the axial
loading forces from the bone to the proximal screws, which transfer the load into
the plate; this load is then transferred from the plate back to the distal bone
segment via the distal screws. Ground reaction forces are controlled in the same
manner but in a reverse direction. The resulting shear (frictional) forces across the
plate-bone interface concentrate stress at the plate-screw-bone unit (2,22). The
plate-screw-bone unit exerts shear forces along the bone-screw thread interface
as a result of the torque applied to the screws during insertion when fixing the plate
to the bone (approximately 3–5 Nm for 3.5 mm cortical screws placed into human
femur) (23,24). The mechanical stability of the plate is affected by how well it is
fitted against the surface of the bone (2). With the use of DCP, as the screw is
being tightened, the screw head slides down on the decline slope within the screw
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hole, converting the descending movement of the screw into a gliding movement
of the plate (2). Therefore, during the implant placement, the screw torque
generates relative compressional strain on the bone surface and tension in the
cortical bone around the screw threads (2). Each screw in this construct is loaded
individually at the screw-bone interface and the farthest screws at each end of the
plate tend to experience the largest interface loads (25).
Although the entire construct can be tested via compression, bending, and torsion
of the plate-screw-bone construct, those tests do not assess individually the
integrity of each screw-bone interface. Peak reversal torque is a valid method to
evaluate the implants interface as an indicator of osseointegration.
Osseointegration has been positively correlated with the loading conditions around
the implant. The axial strength of the plate may be predicated on the axial strength
of the weakest screw in the plate-screw-bone construct because this weakening
results in transference of loading forces to adjacent screws. The evaluation of each
screws' osseointegration provides insight into this aspect of the plate-screw-bone
construct stability. Although the PRT of the various screws has been studied, to
our knowledge, studies on reverse torques of screws used in plate-screw-bone
constructs after periods of loading are lacking.
The objectives of this study were to measure the peak reverse torque (PRT) of
each screw used in a plate-screw-bone construct at the time of its removal after
60 days of in-vivo loading in a non-load sharing, 2.5 cm segmental defect in goats.
We hypothesized that the PRT would vary among the screw positions as a result
of the cyclical loading construct biomechanics. Secondly, we hypothesized that the
ST screws used to fix the plate would have superior PRT compared with that of
NST screws after 60 days of cyclical loading.
Materials and Methods
Animal study: The goats in the study were participating in a research project
studying bone healing of a non-load sharing, mid-diaphysis segmental defect (2.5cm length) of the tibia under an approved protocol (KSU IACUC # 2947) (Figure 31, all figures and tables are placed in the appendix). The goats participating in the
study were mix bred adult (>2 years old) female goats weighing 35 to 65 kgs
purchased from the local vendors for the research purpose and owned by the
university. The goats were healthy and without evidence of lameness or bone
abnormalities. Briefly, the defect creation procedure was performed under general
anesthesia which was maintained with the Isoflurane a gas inhalant (2.5% - 4%
MAC at the beginning of anesthesia and 1.5% MAC – 1.0% MAC during the
procedure). The goats were sedated with 0.05 mg/kg, IV Xylazineb (20 mg/ml) and
induced with 5mg/kg IV Ketaminec (100 mg/ml) and 0.25 mg/kg IV Midazolamd (5
mg/ml). During the defect creation procedure an 8 - hole 4.5 mm 316L stainless
steel DCPe and 3.5 mm 316L stainless steel cortical bone screws e were used to
stabilize the bone. Each bone segment (proximal, distal) received 3 screws. For
statistical analysis, screw positions in the proximal bone segment were assigned
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positions 1, 2 and 3 from proximal to distal. Screws placed in the distal bone
segment were assigned positions 4, 5 and 6 from proximal to distal. Goats were
monitored for lameness daily during the study periods to assess the use of the
operated limb.
In each goat, the DCP were fixed with only one type of screw, either NST cortical
screws or ST cortical screws. All the screws used for this study were placed in
standard AO/ASIF fashion and all were bi-cortical screws (near and far cortex).
Briefly, the thread hole (2.4 mm diameter) was drilled with 12 V battery operated
performance drillf (maximum torque 19.21 Nm) and in the NST screws group it was
tapped manually prior to the screw placement. Both screw types (NST and ST)
were placed manually, using a handheld screwdriver. The screw lengths ranged
between 18 mm to 24 mm, the core diameter equaled 2.4 mm, the thread diameter
equaled 3.5 mm, and the thread pitch equaled 1.25 mm. The screws were inserted
by three of the surgeons (DEA, JR, and JL) and the method was uniformly used
by all surgeons. It has been recommended that the tapered tip and cutting flutes
extend beyond the far cortex, therefore a care was taken that at least 3 threads of
the screw were anchored in the far cortex to maintain rigid fixation (35). All DC
plates were fixed with 6 screws in total; 3 proximal to the osteotomy and 3 distal to
the osteotomy (Figure 3-1). The screws remained in place for 60 days (40) and
were removed at the termination of the study period. Radiographic images were
obtained for all goats on days 7, 14, 30, and 60 of the study periods, and they were
evaluated to document the occurrence of transcortical diaphyseal tibial fractures
in the cortices evident on radiographs and any change in screw-plate-bone
interface, position, and fracture gap.
After 60 days of the study period the goats were euthanized with overdose of
pentobarbital administered intravenously. Euthanasia was induced by rapid
intravenous injection into the jugular vein using pentobarbital (100 mg/kg body
weight, IV) in accordance with the AVMA guidelines on the euthanasia of goats
(41). Pentobarbital rapidly induces unconsciousness without excitation. Death was
confirmed by cessation of any detectable heartbeat and breathing, and loss of
corneal reflexes. All implants were removed in the same manner, starting from the
most proximal position (1) and following the order (from 1 to 6) until the most distal
screw (6). The plate was stabilized manually and therefore prevented from its
movement during implant removal. The peak reverse torque for each screw was
measured using a handheld torque driverg. The pressure was applied gradually
increasing, until the screw turned and then stopped. The torque driver did not
require calibration and zeroing prior to the test. The handheld torque driver
measured torque in the range between 0 – 22.6 Nm. After the implants had been
removed and the tissues had been harvested for histopathology within the study
on the bone regeneration, the cadavers were disposed at the Kansas State
University.
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Data was analyzed using a mixed-effects multinomial logistic regression model
with the reverse torque categories as the multinomial outcome variable and the
screw type (non-self-tapping and self-tapping) as well as screw position in the plate
(proximal to distal with the increasing numbers from 1 to 6) as the fixed
independent effects (multinomial exposure variable). The Odds Ratios, as well as
95 % Confidence Intervals (95% CI) for fixed effects (screw type and screw
position), were estimated with the reference to the screw position no. 6 and selftapping screw type while holding other effects constant. Statistical significance was
identified at the level of p < 0.05. The statistical analysis of the association
between the transcortical diaphyseal tibial fractures and the screw type as well the
fractures and PRT was done using two-sided Fisher’s exact test. Statistical
Analysis was performed using PROC GLIMMIX in SAS9.4 TS1M4 for Windows
64xh.
Results
All goats remained weight-bearing throughout the study period. A total of 318
screws were used for the study, of which the PRT data for 76 screws were not
included in the PRT study due to the following factors: large callous formation
around the plate and screw heads (3 plates), plate bending (4 plates), goat removal
from the study prior to 60 days (3 plates) and device reading errors (16 screws).
The plate bending observed in 4 constructs occurred in goats which showed
subjectively evaluated higher level of activity as compared to the other goats.
There was no relationship between the weight of the goat and bending of the
construct. The remaining 3 goats were removed from the study approximately 1
month after the procedure due to the pullout and displacement of the three most
proximal screws resulting in the plate displacement more than 1 cm away from the
tibia. The peak reverse torques of 242 screws were included in this study, of which
176 were NST screws and 66 were ST screws (Table 3-1).
Based on evaluation of the initial results of the PRT measurements, PRT data was
categorized into four reverse torque ranges: low (t = 0 Nm), medium (0 Nm< t
<0.66 Nm), high (0.66 Nm< t <2.60 Nm) and maximal PRT (t > 2.60 Nm). After 60
days of loading, 9.09% of all NST screws, as well as 4.55 % of all ST screws, were
placed in the low PRT category (t = 0 Nm). The 38 ST screws and 44 NST screws
(58% of all ST screws and 25% of all NST screws respectively) exceeded 22.6
Nm, the maximum range of the torque driver.
The two-sided Fisher’s Exact Test revealed that the transcortical diaphyseal tibial
fractures occurred significantly more frequently in the NST screws group (p < 0.05).
The fractures however did not influence the PRT after 60 days (p > 0.05). During
the placement of the screws, the transcortical diaphyseal tibial fractures occurred
in 37 NST screws and in 5 ST screws (21% of all NST screws and 8% of all ST
screws, respectively). The transcortical fractures were most often observed in the
screw position no. 4 and no. 5 (41.4% and 31.03% of all transcortical fractures in
NST screws group, respectively) (Table 3-2). The pattern was not observed in the
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ST screws where the fractures were equally distributed between each position,
from 1 through 5 (20% of all fractures in each position in ST screw group) (Table
3-2).
Statistical analysis revealed significant differences between the NST screw PRT
and the ST screw PRT (p <0.05). NST screws were significantly more likely to
result in PRT less than 0.66 Nm (Table 3-1). ST screws were significantly more
likely to have PRT greater than 0.66 Nm (Table 3-1). Significant differences in PRT
were found based on the screw insertion position. Screws placed in the proximal
tibia (positions 1, 2, and 3) had significantly lower PRT as compared with those
placed in the distal tibiae (position 4, 5, and 6) (Table 3-1). The relationship of
screw position and PRT was similar among ST and NST screws (Table 3-1).
Discussion
To our knowledge, measurement of PRT has not been reported after a sustained
period of loading in-vivo. The model used herein is a non-load sharing model
resulting in significant cyclical forces being applied to the bone-screw-plate
construct and especially at the bone-screw interface. Similar to previous studies,
the DCP provided adequate fixation with satisfactory stability for the non-load
sharing tibia defect during this 60-day period of study (17-19).
Screws placed proximal to the ostectomy tended to exhibit lower PRT than the
screws placed distal to it. Lower torsional forces needed to break the bone-implant
interface have been related to less implant osseointegration (3,5-6,13-16). There
are several factors which are of importance in the osseointegration process:
biocompatibility, surface quality, surgical technique, the status of the host tissue,
and loading conditions (3,7). In the DCP-screw-bone construct, the screws on each
end of the plate tend to be exposed to higher loads (2,22) and this has been
negatively associated with implant osseointegration (3,7). Bottland et al showed
that screws placed remotely to the fracture or osteotomy sustain greater loads than
the screws adjacent to the fracture (26). The reduced exposure to mechanical
forces may allow for improved osseointegration resulting in greater extraction
torques (26). Repeated loading delays bone on-growth around the implant
lessening osseointegration (1,11,26). In this study, proximal screws exhibited
lower PRT which was most likely due to higher absorption of repeated load than
the distal screws. This phenomenon was less clearly observed in the ST screw
group. This may be related to the already proven increased insertional torque and
primary stability of the ST screws (27-31). PRT has been shown to have a positive
correlation to the surrounding bone quality (3,6,11). Several studies have shown
that the tibiae have lower BMD in the proximal-mid part of the bone and greater in
the distal portion (32-34). The goats used for our study were adult, healthy, and
free of lameness or pathologic bone condition. Thus, we would expect that BMD
likely influenced some of the PRT results.
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ST screws exhibited greater peak reverse torques (PRT) than NST screws after a
period of 60 days of loading in a screw-plate-bone construct. The ST screw threads
placed into the bone are expected to more closely contact the bone surface with
compression as compared with NST screws due to the lack of the tapping process
prior to the screw placement (1,35). The tap device designed for use with NST
screws has been shown to have longer threads than the screws and this
discrepancy creates a micro space between the screw thread and cut bone (35).
This incongruity can result in implant micromotion (35) which can reduce the
primary stability of the screws. Several studies have shown that the ST screws
exhibit greater peak insertional torque (PIT) than the NST screws (1,5,16,36).
According to these studies, ST screws obtain greater primary stability than the NST
screws (3) and show better interfacial stiffness at the implant-bone interface (4).
Micromotion causes filling of the space between the bone and the implant with
fibrous tissue or encapsulation of the implant (5). Moreover, this process can lead
to excessive bone resorption and inflammation around the implant (peri-implantitis)
(4,5,35). These processes will result in reduced implant secondary stability which
will negatively influence the longevity of the implant as reflected by decreased
PRT. In contrast, the ST screws due to their greater insertional stress have been
associated with increased incidence of bone damage promoting bone failure (1)
and transcortical diaphyseal tibial fractures (35). These incidences may reduce
primary as well as secondary stability. In contrast, the number of transcortical
diaphyseal tibial fractures in our study was greater within the NST screws than in
ST screws.
The length of the NST and ST screws ranged between 18 and 24 mm in our study
and all of the screws were placed bicortical. Previous research on a different length
of the orthodontic implants (1.4 – 3.8 mm) did not show any significant correlation
between the length of the implant and PRT as long as the implant was longer than
1.4 mm, which was considered as implants’ minimal length (37). The minimal
length of the cortical screw is considered when at least 3 threads of the implant
can be placed through the far cortex in order to achieve the rigid fixation (1). In this
study in all cases at least 3 threads of the screw were anchored in the far cortex.
The mean PRT of ST and NST screws in this study are comparable with the
previous studies on PRT of screw implants. PRT values vary between studies due
to factors affecting the osseointegration process and different materials used for
the biomechanical tests (3,14,38).
Reverse torque can be a valid method to assess the biomechanical properties of
orthodontic implants. This method has been used to reach a better understanding
of the osseointegration process (3-7,10-16). The term ‘integration strength’ refers
to the force required to break the bond between the implant and the bone, and this
can be measured with the PRT (4). Okazaki et al. showed that insertional torque
positively influenced PRT immediately after implant placement. However, the PRT
decreased with healing time and showed no difference between the screws at
weeks 6, 9, and 12 after insertion (4). Biomechanical interlocking decreases over
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time but may increase again as remodeling of the surrounding bone takes place
(5). Histological examination of the bone healing process around titanium implants
has shown that the existing bone initially resorbs at the bone-implant surface and
is replaced by newly formed bone (5). The screws in our study were used in a nonload sharing segmental defect of the tibiae model in goats for approximately 8
weeks resulting in varied reverse torques between ST and NST screws. Some
investigators have observed a positive correlation between the bone-implant
contact (BIC) and PRT (13,15) while others claimed that the bone quality formed
around the implant is more important than the amount (3,6,11,14).
The main limitation of this study is the lack of measured peak insertional torque
(PIT) during the screw placement. Even though the PIT defines implants primary
stability (1,26,39) not their secondary stability (3) which was measured in this
study, it could have been used to standardize the screw placement within the plate.
In this study however, limitations of equipment and study design prevented
measurement of insertion torque, therefore the variability of insertion torque may
have contributed to differences in PRT. Next, the torque unit was limited in a range
which resulted in the inability to measure low and high range torques. The torque
cell had been selected based on expectations derived from previous studies.
Finally, hence this in-vivo study was a part of another research project, introducing
the control group was not possible. The control group would have consisted of the
screws on which the primary stability would have been measured. The screws
would have been placed in the same fashion as described above and they would
have been removed immediately after their placement. The PRT would have been
measured right before the implant removal. These are the weaknesses that may
be addressed in future work.
Conclusions
The DCP-screw-bone construct is an adequate fixation method providing a
sufficient stabilization in this 2.5 cm tibial defect model. The construct stabilization
can be assessed by measuring implants osseointegration. The ST screws were
shown to have a stronger bone-implant interface based on better PRT as
compared with NST screws after 60 days post-implantation. Screws placed in the
proximal tibia exhibited significantly lower peak reverse torque than those placed
in the distal tibia. The lower reverse torque in the proximal tibia may be influenced
by load distribution in the goats’ tibiae-plate assembly or because of different bone
density between the proximal and distal parts of the bone. This phenomenon was
less evident in the self-tapping screws presumably because of the greater primary
stability as compared with non-self-tapping screws.
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Tables
Table 3-1. Peak Reverse Torque categories for NST and ST screws.

Peak Reverse Torque Groups
NST Screws (Number)

Prox
to Max High Med
Dist
5
8
13
1
5
13
9
2
4
2
14
3
9
12
8
4
8
5
5 16
9
11
9
6
54
58
Total 48
% of
27% 31% 33%
total

ST Screws (Number)

Low

Total

Max

High

Med

Low

Total

4
2
9
0
0
1
16

30
29
29
29
29
30
176

3
4
5
9
9
8
38

3
4
4
1
2
3
17

3
3
2
0
0
0
8

2
0
0
1
0
0
3

11
11
11
11
11
11
66

26%

12%

5%

100%

9%

100% 57%

Most of the NST screws PRT were categorized as High and Medium, whereas the
ST screws PRT were mostly categorized as Maximal and High. Overall screws in
the position 1-3 were categorized as Medium and Low, whereas the distal screws
in positions 4-6 in the majority were categorized as Maximal and High in both screw
types (ST and NST). The last line of the table presents the percentage of overall
screws placed in the different categories.
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Table 3-2. Prevalence of cortical fractures within each screw type.

Screw Type

Position
1
2
3
4
5
6

Total
(n)
30
29
29
29
29
30

NST
Intracortical Intracortical
Fracture
Fracture
(n)
(%)
2
6.7
6
20.7
5
17.2
12
41.4
9
31.0
3
10.0

Total
(n)
11
11
11
11
11
11

ST
Intracortical Intracortical
Fracture
Fracture
(n)
(%)
1
9.1
1
9.1
1
9.1
1
9.1
1
9.1
0
0

The intracortical fractures occurred in the trans cortex more frequently during the
placement of the non-self-tapping screws (37) as compared with the self-tapping
screws (5). The position most commonly associated with the fractures were
position no. 4 and position no. 5 in the NST screws group. In the ST screws group
the fractures were more equally distributed between the positions.
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Figures

Figure 3-1. Goat tibial defect ostectomy.
Goat tibial ostectomy model supported with an 8 – hole dynamic compression plate
(DCP). The 2.5 cm defect was created in the mid-tibia and the plate was fixed with
6 ST or NST screws placed proximally to the ostectomy (pos. 1 – 3) and distally
(pos. 4 - 6). The two white circles are labeling the transcortical diaphyseal tibial
fractures.
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Abreviations
BMD – Bone Mineral Density
BIC – Bone Implant Contact
DCP – Dynamic Compression Plate
IV – Intravenous
MAC – Minimal alveolar concentration
NST – Non-self-tapping
PRT – Peak Reverse Torque
PIT – Peak Insertional Torque
RF – Resonance Frequency
ST – Self-tapping
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Footnotes
a.
b.
c.
d.
e.
f.
g.
h.

Isoflurane, Abbott Laboratories Inc., 100 Abbott Park Road, Abbott Park,
IL60064, USA
AnaSed, Lloyd Laboratories Inc., #10 Lloyd Avenue, First Bulacan
Industrial City Brgy Tikay, City of Malolos, Bulacan, Philippines
Ketamine, Pfizer Inc., 235 East 42nd Street NY, NY 10017, USA
Midazolam, AmerisourceBergen Inc., 1300 Morris Drive, Chesterbrook,
PA 19087, USA
Dynamic Compression Plate, Self-tapping and Non-self-tapping screws,
DePuy Synthes Inc., 325 Paramount Dr. Raynham, MA 02767, USA
Performax 12 V 3/8” cordless drill, 5101 Menard Drive, Eau Claire, WI
54703, USA
Electrotorque System TQJE1500, Snap-on Inc, 2801 80th Streer
Kenosha, WI 53143, USA
SAS Institute Inc. 100 SAS Campus Drive, Cary, NC 27513 – 2414, USA
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CHAPTER FOUR
ASSESSMENT OF A 3D HYDROPHILIC POLYURETHANE
SCAFFOLD CONTAINING NANO-HA AND BONE PARTICLES,
WITH OR WITHOUT BMP2 OR MESENCHYMAL STEM CELLS,
ON BONE REGENERATION AND NEOVASCULARIZATION OF
MASSIVE (> 5CM) SEGMENTAL DEFECTS
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Abstract
Background
Large segmental bone defects (>5cm) result from a traumatic injury and are often
associated with extremity amputation. This research provides a valuable
alternative to restore such defects with novel nano-based bone scaffolds (PU-nHADBP). 61 female and mature goats were included in this study. The goats were
randomly assigned to 4 treatment groups with average of n=8, including control,
bone scaffold only, bone scaffold soaked in rhBMP-2 and bone scaffold coated
with cMSC (n=7) as well as to 2 different study time points, including 2 months
(n=31) and 6 months (n=30). Bone healing was evaluated using HD IR
Thermography, Radiography, Dual X-ray Absorptiometry (DXA), Dual-phase
quantitative Computed Tomography – Angiography as well as Histology.
Peripheral blood was collected for the VEGF and BMP-2 measurements.
Results
The results of the bone healing assessment methods revealed significantly more
dynamic bone regeneration within the bone scaffold with the cMSC treatment
group. The defect healing within the bone scaffold rhBMP-2 and bone scaffold
were comparable and significantly higher when compared to the controls. Neither
the bone scaffolds nor the bioactive agents significantly stimulated the
macroscopic neovascularization process. The peripheral blood BMP-2
concentration increased in a linear manner in all treatment groups and the highest
increase was observed in the scaffold rhBMP-2 group.
Conclusions
The bone scaffolds showed promising results in the restoration of large segmental
tibial defects (>5 cm) in a goat animal model. None of the implants presented
adverse defects in the body associated with implant rejection.
Introduction
The injuries of the musculoskeletal system are a significant problem in human
orthopedics. Although the bone has extremely high potential to regenerate itself
after damage (1-3) the efficacious repair of large bone defects resulting from
resections, traumas, large defects or non-union fractures still requires the
implantation of bone grafts (4-5). To date, the optimal bone grafts include the grafts
from autologous bone harvested from the donor site of the individual. The
significant disadvantage of those grafts is however associated with the increase of
morbidity after the implantation and with the necessity of a second surgery (6).
Therefore, the orthopedic research seeks to create the synthetic allografts which
would reduce the morbidity and eliminate the requirement for additional surgery.
The three-dimensional porous bone scaffolds with interconnected channels aim to
provide an appropriate base for tissue growth and cell proliferation (7) as well as
stimulate bone regeneration with incorporated cells and or growth factors (8).
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An ideal bone scaffold should have enough porosity to accommodate osteoblasts
or osteoprogenitor cells, to support cell proliferation and differentiation, and to
enhance bone tissue formation (9). The early cellular ingrowth, as well as rapid
microvascular network formation, has been found to be optimal in the implants with
the pore size ranging from 50 to 300 µm diameter (9-11). The larger channels of
500 to 800 µm diameter support ingrowth or larger vessels which directly influence
the bone regeneration (9-11). The neovascularization is one of the most important
processes in the newly regenerated bone, as it provides oxygen and nutrients to
the regenerating bone tissue (12-16). The process occurs most dynamically during
the early stages of bone healing (14). The aim of the synthetic biomaterials is to
enhance the bone healing and a variety of them have been tested. Polyurethanes
are frequently employed in the biomaterials due to mechanical and biological
advantages and recently they have gained interest as the platform used for the
bone scaffolds (11,17-24). Furthermore, depending on the synthesis method the
porosity in the material can be controlled in a feasible way (11).
This study utilizes a novel technology bone scaffold technology that consists of the
unique combination of three-dimensional and completely resorbable polyurethane
platform (PU) coated with a nanophase Hydroxyapatite (nHA) and decellularized
bone particles (DBPs) (25,26). The pore size varied between 50 and 800 m. The
scaffold technology utilized in this research differs from those utilized in previous
reports on polyurethane implants coated with nano-Hydroxyapatite in patented
manufacturing methods as well as in the polyurethane platform (25-30). The novel
technology implants are evaluated in the large animal (goat) model with a large
(>5 cm) full-thickness segmental tibial defect. The study evaluates implants'
influence on the neovascularization process during a short postoperative period
and within the newly formed bone throughout the healing process.
The first objective of this study (O1) was to assess scaffolds bone regenerative
properties, specifically its ability to enhance the neovascularization process within
2 and 6 months after the surgery. The bone scaffold was compared to the bone
void (negative control) as well as to the scaffold coated with the recombinant
human bone morphogenetic protein-2 (BMP-2) and scaffold seeded with caprine
mesenchymal stem cells (cMSC). Both bioactive agents have been already proven
to have a positive influence on bone regeneration, and BMP-2 furthermore has
been described to mediate proangiogenic effects (31-34). The second objective of
this study (O2) was to evaluate the recombinant human bone morphogenetic
protein – 2 (rhBMP-2) and caprine mesenchymal stem cells (cMSC) influence on
the bone regeneration and neovascularization process. The third objective (O3)
was to evaluate the vascular endothelial growth factor (VEGF) and bone
morphogenetic protein-2 (BMP-2) concentration within the peripheral blood. The
first hypothesis (H1) was that the bone scaffold will be osteoinductive,
osteoconductive and osseointegrated and will therefore stimulate bone
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regeneration of the large tibial defect. The second hypothesis (H2) was that it will
further enhance the early neovascularization process. The third (H3) and fourth
hypothesis (H4) were that the bone regeneration and neovascularization will be
different between the treatment groups including scaffolds, scaffolds coated with
BMP-2 and scaffolds seeded with cMSC. The fifth hypothesis (H5) was that there
will be a difference in the peripheral blood VEGF and BMP-2 concentration
between the treatment groups depending on the pace of bone regeneration. The
bone regeneration was defined by tissue ingrowth and on growth caused by
implants osteoinductive, osteoconductive and osseointegrative properties (35).
Materials and Methods
Study Population
The study included 61 mix-bred adult (>2 years old) female goats weighing
between 35 and 65 kgs. The goats underwent a routine screening process before
the acquisition which consisted of general clinical health assessment and
orthopedic evaluation. Any goat which showed clinical signs of a chronic disease,
bad body condition score (1-2/5), signs of lameness due to an underlying disease
or was positive for pregnancy screening was not included in the study. The length
of the right tibiae varied between 22 and 25 cm. 61 goats were included in the
study and randomly assigned to 4 treatment groups (n=7-8 goats per group) and
2 study termination time points. The treatment groups involved negative control
with the bone defect left unfilled, and the scaffold containing treatment groups,
including bone scaffold, bone scaffold coated with e-coli derived recombinant
human bone morphogenetic protein – 2 (rhBMP-2)a and bone scaffold seeded with
the bone marrow-derived caprine mesenchymal stem cells (cMSC). The goats
were humanely sacrificed at 2 study termination time points, including 60 days after
the surgery and 180 days after the surgery. The study was performed under a
protocol that was approved by the University of Tennessee Institutional Animal
Care and Use Committee under protocol number 2606-0518.
Nano-HA polyurethane scaffold preparation
The nano-HA polyurethane scaffolds with demineralized bone particles were
prepared as previously described (25,26). Each of the Nano-scaffolds assigned to
the rhBMP-2a treatment group was soaked in 2 mg of rhBMP-2a (1mg/ml) 15
minutes before implantation into the defect. The rhBMP-2a was applied on the
scaffold surface during the surgery by the surgeon in sterile manner. Each of the
bone scaffolds assigned to the cMSC treatment group was sterilely loaded with the
low passage (P2-4) 5 x 106 cMSC/cm diameter 24 hours before implantation.
Caprine Mesenchymal Stem Cell Collection and Culture
The bone marrow was harvested from the goats’ sternum in the presence of 1 ml
of 1,000 USP units/ml heparin per 10 ml of harvested bone marrow, using a
previously described technique (36-38). The collected bone marrow was added to
a T175 tissue culture flaskb and incubated at 37°C with 5% CO2 for 48 hours.
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Adhered cells were washed with addition of HBSS c to remove extraneous blood
agents and growth media, Dulbecco’s Modified Eagle Medium with glutamine, 4(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES buffer), and sodium
pyruvate added (DMEM/F-12 1:1 modified)d containing 10% fetal bovine serume
(fetal bovine serum) and a 1% solution of 10,000 units/ml of penicillin f and 10,000
µg/ml streptomycing (penicillin-streptomycin solution) was added. Cell cultures
were expanded by regular media changes every 3 days until the cells reached 80%
confluency, at which point cells were harvested using 0.25% trypsinh. Harvesting
and seeding cycles were repeated to generate a stock of cells passage 2-4. For
storage, aliquots of 10 million bone marrow-derived cMSCs were resuspended in
1.5mL freezing medium, comprised of 50% fetal bovine serum, 5% dimethyl
sulfoxide (Hybri-Max)i, and 45% of DMEM/F-12 1:1 modified media, and
cryopreserved in liquid nitrogenj. For application, cells were thawed at 37°C, and
re-suspended gently with DMEM/F-12 1:1 modified media and were carefully
seeded to scaffolds 24 hours prior to implantation at a concentration of 5x10 6
cMSC/cm of scaffold length.
Surgical Procedure and Postoperative care
The goats received antibiotics including ceftiofur sodium k 2.2 mg/kg IV and antiinflammatories including flunixin meglumine l 1 mg/kg for 3 days around the surgery
time. Before the anesthesia, they were sedated with xylazine hydrochloridem (0.05
mg/kg IV) and induced under general anesthesia using ketamine hydrochloride n
(5mg/kg IV) and midazolamo (0.05 mg/kg IV). General anesthesia was maintained
in dorsal recumbency using Isofluranep and oxygen. The right hind limb was
clipped, aseptically prepped and draped accordingly to the surgery. A 20 cm skin
incision was made over the dorsal and medial aspect of the right tibia to expose
the bone and 5-7 cm full-thickness defect was created in the mid tibia with the
oscillating bone sawq. The defect was stabilized with a 4.5 mm 8 holes – locking
plater which was applied to the dorsomedial surface of the tibia. The plate was
fixed to the bone with eight bi-cortical screwss, four in the distal and four in the
proximal aspect of the tibia. The created void in the bone was thoroughly washed
with a 10% gentamicint solution and the defect was filled either with the scaffold
accordingly to previous treatment group assignment or left unfilled in the control
group. The subcutaneous tissue was closed using absorbable taper suture u in the
simple continuous manner and the skin incision was closed using a simple
continuous pattern with non-absorbable cutting suturev. A sterile bandage with the
full limb splint support was applied to the right hind limb and the goat was
recovered on the mat. During the postoperative care, the goats were housed
individually for up to 30 days after the surgery and following that in the group pens
containing 5-6 goats. The sutures were removed 30 days after the surgery and the
full support bandages were removed 60 days after surgery. The fiberglass cast
was applied to the limbs which required additional stabilization, including limbs with
the locking plate constructs bending or limbs with the excessive periosteal reaction
around the proximal bone due to the construct instability. During the postoperative
91

period, the bone healing assessment data was acquired, including thermography,
radiography, dual X-ray absorptiometry (DXA), dual-phase Computed
Tomography (CT) Angiography as well as histology. The peripheral blood was
collected over several time points to evaluate the VEGF and BMP-2 concentration.
High Definition Infrared Thermography (HD IR Thermography)
Thermography was performed on the operated right hind limb to evaluate the blood
flow in the local tissues associated with the inflammatory process using the high
definition infrared thermometer cameraw. The camera was adjusted to the
surrounding environment including the temperature and humidity each time before
the data acquisition process was started. The acquisition process was
standardized, and it was performed by two investigators (RG and RR). The scans
were acquired 10 minutes after the bandage was removed. The scans were
obtained 1 m away from the operated limb with the device directed perpendicularly
to the limb and aimed at the area of interest in the center of the right tibia. Two
projections obtained every time included the anterior-posterior projection as well
as the latero-medial projection. The temperature was measured in both projections
in degrees of Celsius and the average value was recorded.
Radiography
The new bone formation within the defects was assessed with the radiographic
examination. The radiography was performed by two investigators (RG and RR)
using the portable radiographic machinex, digital radiography platesy and a clinical
radiographic digital systemz. The radiography involved two projections, the dorsoplantar and latero-medial projection of the right tibia. The radiographs were
obtained immediately after the procedure, 24 hours after the procedure, followed
by monthly examinations until the end of the study. Obtained radiographs were
exported in digital imaging and communications (DICOM) format to the picture
archival and communication system (PACS)aa for the further analysis by the boardcertified radiologist (SH). The monthly radiographs were evaluated and the gapfilling with new bone (range of scores from 0 to 4) (Table 4-1), opacity of newly
formed bone (range of scores from 0 to 2) (Table 4-2) as well as opacity increase
within the scaffold (0 – no and 1 – yes) were scored. The median scores were
compared between the treatment groups. Next, the defects were monthly
measured in three different locations. The first location consisted of the line drawn
adjacent to the locking plate construct, the second location consisted of the line
drawn in the center of the defect and the third location consisted of the line drawn
in the far cortex. The defects showing evidence of collapse due to the locking plate
bending were excluded from this analysis.
Defect densitometry - Dual X-ray Absorptiometry (DXA)
The bone density of the defects was measured with the dual x-ray absorptiometry
(DXA)bb. The DXA system was calibrated based on two materials of defined
composition, one mineral (hydroxyapatite) and a homogeneous soft tissue of a set
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area adjacent to the bone area. DXA scans were obtained 24 hours after the
surgery followed by monthly examinations until the end of the study. The goats
were sedated with Xylazine hydrochloridem (0.05mg/kg IV) and placed in sternal
recumbency. The hind limbs were extended caudally and the scans of the entire
length of the tibiae parallel to the long axis of the bone were performed. The
scanner was set for the lumbar spine using a single beam and the bone mineral
density (BMD) calculations were performed. The region of interest (ROI) was
drawn between the most distal screw in the proximal bone segment and the most
proximal screw in the distal bone segment. The ROI was subsequently divided into
three segments (L1-L3), including the distal aspect of the proximal bone segment
(L1), the defect (L2) and the proximal aspect of the distal bone segment (L3). All
segments were analyzed in a DXA softwarebb and the report was generated. The
bone area was defined and expressed in cm2 and BMD was calculated and
expressed in g/cm2.
Dual-Phase Computed Tomography (CT) Angiography
The vascular integrity following large defect creation in the tibiae was assessed
with the dual-phase computed tomography (CT) angiography. The CT was
performed using a 40-slice helical CT scannercc. Obtained CT images were sent
to the PACS systemaa for further evaluation by the board-certified radiologist (SH).
The scans were performed before the goat was sacrificed under general
anesthesia at two study termination time points (60 and 180 days). During the
scans, the transverse images of the tibia from the distal aspect of the femur to the
tarsus were obtained prior to contrast medium administration. The images were
acquired as a multi-slice helical data set and were reconstructed into 0.67- and 5mm slices using soft tissue and bone algorithms. The dual-phase CT angiography
consisted of two contrast injection phases, including test bolus of a contrast
mediumdd (185 mg I/kg) administration and a full dose of contrast mediumdd (814
mg I/kg) administration. The number of visible vessels surrounding the defect as
well as their branches were recorded. The contrast enhancement was also
measured as an indicator of vascularity of the tissues within the osteotomy gap.
Attenuation values before contrasting medium administration and during peak
arterial and venous enhancement were determined, and a contrast enhancement
ratio between post- and pre-contrast measurements was calculated. The defect
density was measured using Hounsfield Units (HU).
Histology
The goats received intravenous oxytetracyclineee (20 mg/kg IV) one time, 24 hours
before euthanasia to label the metabolically active bone. After the euthanasia, the
tibia segments were harvested and fixed in 95% Ethanol fixative until sectioned.
The specimens with insufficient healing and tissue integrity to perform whole
segment histology were divided into proximal, middle and distal segments. The
proximal segment included 1-cm of the proximal bone and the transition zone
between bone and the scaffold. The middle segment included 2 cm of the center
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of the scaffold, and the distal segment included 1 cm of the distal bone and the
transition zone between bone and the scaffold. Those samples underwent routine
protocol decalcification process which included preservation in 10% neutral
buffered formalinff for 5 days after tissue biopsy followed by a short, up to 5 days
decalcification with hydrochloric acid gg (39). The specimens were subsequently
stained with hematoxylin-eosin and Masson’s trichrome according to the routine
staining protocols (40-42). Tissues with sufficient bone healing and integrity were
harvested in their entirety and ultimately embedded in methyl methacrylate hh for
staining and analysis (40). The embedding process included tissue dehydration
using an automated tissue processorii and placing the tissues in the infiltration
solution (methyl methacrylate and dibutyl phthalate) for a period of 1.5 - 2 weeks.
Infiltrated tissues underwent following staining, including von Kossa, Goldner’s
Trichrome, Tartrate-resistant acid phosphatase (TRAP) and Verhoeff-Van Gieson
(VVG) accordingly to the routine protocols previously described in the literature
(43-45). For fluorescence microscopy, slides were coverslipped and left unstained
due to the fluorochrome labeling to determine bone formation. Descriptive analysis
and quantitative assessment of the stained specimens were performed. The
quantitative assessment of new bone formation (mineralized tissue) in the proximal
and distal segment as well as the osteoid (unmineralized tissue) formation in the
middle sections was conducted using NIH Fijijj (46,47). The quantification was
carried out through the generation of binary masks for images, permitting
measurement of the mineralized and non-mineralized area relative to the total
image area. Bone and osteoid areas expressed as a percentage of the total area
of images were averaged, and statistical relations among groups obtained.
VEGF and BMP-2 concentration measurement
The peripheral blood was collected from the goats to evaluate the vascular
endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP2)
concentration up to 30 days after surgery. The timeline was established according
to the previous reports, which found the most dynamic changes in the
concentration of those growth factors within the first month of the healing (48). The
collected blood was centrifuged to obtain plasma which was stored in -80°C freezer
until analysis. The analysis was performed using commercially available BMP2 kk
and VEGF ELISA kitsll which allowed for the measurements of the concentration
of each growth factor.
Statistical Analysis
The statistical analysis was performed using IBM SPSS Statistics 25®mm. The
treatment groups assigned to the 2-month time point and 6-month time point were
analyzed separately. The descriptive statistics including mean values as well as
standard deviations of each variable were performed. The continuous variables
were tested for the normality of distribution using the Kolmogorov - Smirnov test
and for the homogeneity of variance using Levene’s test.
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The differences between the treatment groups at each data collection time points
were analyzed using one-way analysis of variance (ANOVA) test with Tukey’s
Post-hoc test with the treatment group as the factor. The changes within each
treatment group over time were evaluated with the bivariate 2 – tailed Pearson’s
correlation test and multivariate regression analysis with the treatment groups as
the dependent variables and time as the covariate. The adjusted R squared as well
as beta coefficients for each dependent variable were obtained and the
significance of each beta coefficient was evaluated. The categorical data were
compared between the treatment groups using the Kruskal – Wallis nonparametric
test. The survival rate of the study population due to a complication occurrence
was calculated using the Kaplan-Meier survival curve. The statistical significance
of the tests was established at alpha equaled 0.05 and the power of the study was
calculated to be β = 0.8.
Results
Study Population
The study included 61 out of 67 mature female goats (> 2 years old). The goats
were assigned to 2 study terminal time points, including 2-month (n = 30) and 6month (n=31). The average size of the defect created in the study was 6.63 ± 1.4
cm in both time points. The average weight of the goats was 51.49 ± 8.0 kg and
55.59 ± 7.9 kg in the 2- and 6-month treatment groups respectively. The calculated
Kaplan-Meier survival curve revealed no statistical difference in the survival rate
between all the treatment groups due to an event that was defined as a
complication (p > 0.05) (Figure 4-1, all figures and tables are placed in the
appendix).
High Definition Infrared Thermography (HD IR Thermography)
The statistical analysis confirmed the normality of data distribution and
homogeneity of variance within all analyzed variables (p > 0.05). The analysis of
data obtained from the goats assigned to the 2-month time point did not reveal
statistically significant differences in the temperature yielded by the local tissues
surrounding the surgery site between all treatment groups at any of the data
collection time points. A statistically significant reduction of local tissue
temperature over 2 months after surgery in all treatment groups was observed (p
< 0.05). This was confirmed with the multivariate regression which was significant
for all treatment groups and yielded following beta coefficients, -0.54, -0.47, -0.41,
-0.58 and R2 values, 0.356, 0.219,0.132,0.090 for the control, scaffold, scaffold
rhBMP-2 and scaffold cMSC treatment group respectively (p < 0.05).
The analysis of data obtained from the goats assigned to the 6-month time point
showed a similar trend, revealing no statistically significant differences in the
temperature of the local tissues at any of the data collection time points (p > 0.05).
A statistically significant reduction of local tissue temperature overtime after
surgery in all treatment groups was confirmed (p < 0.05). Similarly, this was
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confirmed with the multivariate regression which was significant for all treatment
groups and yielded following beta coefficients, -0.74, -0.77, -0.75, -0.80 and R2
values, 0.663,0.710,0.728,0.706 for the control, scaffold, scaffold rhBMP-2, and
scaffold cMSC treatment group respectively (p < 0.05) (Figure 4-2).
Radiography
The subjective radiographic assessment revealed that in the 2- and 6-month time
points treatment groups, the scores of osteotomy gap filling, the scores of newly
formed bone opacity as well as in the scaffold containing treatment groups - the
scores of the opacity increase within the graft did not differ significantly between
all treatment groups (p > 0.05) (Figures 4-3,4-9,4-10, and 4-11). The objective
analysis involved the defect measurement results collected from 40 out of 61 goats
(Figure 4-3). The results from 21 goats were excluded from this analysis due to the
defect collapse during the postoperative period. The statistical analysis confirmed
the normality of data distribution and homogeneity of variance within all analyzed
variables (p > 0.05). The statistical analysis of the results obtained from the 2months treatment groups did not reveal significant differences between the
treatment groups in general reduction of the defect at any of the measurement time
points (p > 0.05) (Table 4-3). Similarly, the detailed analysis of 3 different defect
measurement locations (lines 1,2 and 3) did not reveal significant differences
between the treatment groups in the defect reduction at any of the measurement
time points (p > 0.05) (Table 4-3). This was confirmed with the multivariate analysis
which revealed no significant defect reduction over 2 months after the surgery (p
> 0.05), except for the scaffold only treatment group for which the analysis showed
a significant reduction in the size of the defect measured at the line no. 1 and 2
(beta coefficient = - 0.161, R2 = 0.421 and – 0.113, R2 = 0.610 respectively) (p <
0.05).
The differences between the treatment groups in defect reduction were more
noticeable in the goats assigned to the 6-month time point (Table 4-3). The
calculated defect reduction slope was more dynamic within the first 3 months after
surgery yielding -0.093 mm/day, -0.099 mm/day, -0.126 mm/day, -0.338 mm/day
for the control, scaffold, scaffold rhBMP-2 and scaffold cMSC treatment group
respectively. The slope plateaued after 3 months post-surgery, resulting in -0.028
mm/day, -0.073 mm/day, -0.060 mm/day, -0.125 mm/day in the control, scaffold,
scaffold rhBMP-2 and scaffold cMSC treatment group respectively (Figure 4-4).
The statistical analysis of the general defect reduction revealed significant
differences from the 3rd month after the surgery in the size of the defect between
the scaffold cMSC and the remaining treatment groups (p < 0.05) (Table 4-3). The
detailed analysis revealed that the defect reduction in scaffold cMSC differed
significantly from the control treatment group 4-, 5- and 6-months after surgery in
the line no. 3 as well as from the scaffold in the line no.1, 4 months after surgery
and in the line no. 3, 4-, 5- and 6-months after surgery (p < 0.05) (Table 4-3). The
analysis of the measurements in the remaining line no.2 did not reveal significant
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differences in the defect size between the treatment groups at any of the data
collection time points (p > 0.05) (Table 4-3). The results of the multivariate
regression analysis of the measurements taken in line no.1 were statistically
significant for all treatment groups and yielded following beta coefficients, -0.121,
-0.098, -0.151, -0.311 and R2 values, 0.155, 0.087, 0.286, 0.376 for the control,
scaffold, scaffold rhBMP-2, and scaffold cMSC treatment group respectively
(Figure 4-4). The multivariate regression analysis of the measurements taken in
line no.2 was statistically significant only for the scaffold containing treatment
groups and yielded following beta coefficients, -0.093,-0.076, -0.301 and R2
values, 0.097, 0.128, 0.335 for the scaffold, scaffold rhBMP-2 and scaffold cMSC
treatment group respectively (Figure 4-4). The multivariate regression analysis of
the measurements taken in line no.3 was statistically significant only for the
scaffold cMSC treatment group and the beta coefficient equaled -0.273, as well as
R2 value, equaled 0.309 (Figure 4-4).
Densitometry - Dual X-ray Absorptiometry (DXA)
The statistical analysis of the DXA results confirmed the normality of data
distribution and homogeneity of variance within all analyzed variables (p > 0.05).
The bone mineral density (BMD) recorded on the tibiae in the goats assigned to
the 2-month time point varied between the treatment groups. At the 2-months data
collection time point, the statistical analysis revealed significant differences in BMD
between the treatment groups containing the scaffold and the controls (p < 0.05)
(Table 4-4, Figure 4-5). The differences were however not statistically relevant
between the scaffolds containing treatment groups (p > 0.05) (Table 4-4). The
calculated BMD slopes varied between the treatment groups revealing 0.001
g/cm2/day, 0.004 g/cm2/day, 0.005 g/cm2/day for the control, scaffold as well as
scaffold rhBMP-2 and scaffolds cMSC treatment group respectively. The
multivariate analysis confirmed the trend yielding following beta coefficients, 0.001,
0.04, 0.001, 0.005 and R2 values, 0.077, 0.711, 0.665, 0.537 for the control,
scaffold, scaffold rhBMP-2 and scaffold cMSC treatment group respectively (p <
0.05).
At 6-months data collection time point, the statistical analysis revealed significant
differences in BMD between the treatment groups at all data collection time points
(p < 0.05) (Table 4-4, Figure 4-5). The differences in BMD were found between the
groups containing the scaffolds and the control (p < 0.05) (Table 4-4). Further
analysis found statistically significant differences between the scaffold cMSC and
the scaffold treatment group revealing lower BMD in the scaffold cMSC, 24 hours
after the surgery and higher BMD in the scaffold cMSC, 4 and 5 months after the
surgery (p < 0.05) (Table 4-4). The BMD was also significantly higher in the
scaffold cMSC as compared with the scaffold rhBMP-2 at 4, 5 and 6 months after
the surgery (p < 0.05) (Table 4-4). The differences between the scaffold and the
scaffold rhBMP-2 were not statistically significant (p > 0.05) (Table 4-4). The
calculated BMD slope showed its most dynamic increase during the first 3 months
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revealing 0.0005 g/cm2/day, 0.0023 g/cm2/day, 0.0024 g/cm2/day, and 0.0048
g/cm2/day increase within the control, scaffold, scaffold rhBMP-2, and scaffold
cMSC respectively (Figure 4-6). After 2- and 3-months post-surgery, the BMD
slopes gradually plateaued in all treatment groups, resulting in 0.0013 g/cm 2/day,
-0.0014 g/cm2/day, -0.0014 g/cm2/day, and 0.0021 g/cm2/day increase in the
control, scaffold, scaffold rhBMP-2 and scaffold cMSC treatment group
respectively (Figure 4-6). The multivariate regression confirmed the trend and it
was significant in all treatment groups yielding following beta coefficients, 0.000,
0.001, 0.001, 0.004 and R2 values, 0.075, 0.126, 0.126, 0.351 for the control,
scaffold, scaffold rhBMP-2 and scaffold cMSC treatment group respectively (p <
0.05) (Figure 4-6).
Dual-Phase CT Angiography
The statistical analysis of results obtained from the computed tomography (CT)
with angiography confirmed the normality of data distribution and homogeneity of
variance within all analyzed variables (p > 0.05). Further analysis of the results
obtained from 2-month treatment groups revealed that defect density was
significantly different between the scaffold containing treatment groups and the
control (p < 0.05). The results were however not significantly different between the
treatment groups containing scaffolds (p > 0.05) (Table 4-5). The density of newly
formed bone and the number of newly formed vessel branches within the defect
did not differ significantly between the treatment groups (p > 0.05) (Table 4-5). The
number of vessels contacting the implant did not differ significantly between the
treatment groups containing scaffolds (p > 0.05) (Table 4-5). The contrast
enhancement ratio was significantly higher in the scaffold as compared with the
scaffold cMSC treatment group (p < 0.05) (Table 4-5). Further analysis revealed
that the cortical density of the proximal and distal bone fragment was significantly
different between the operated limb and non-operated limb in control, scaffold
rhBMP-2 and scaffold cMSC treatment group (p < 0.05). The difference was not
statistically relevant in the scaffold treatment group (p > 0.05). The muscle mass
of the gluteal muscle group was significantly different in the non-operated limb as
compared with the operated limb in the scaffold and scaffold cMSC treatment
group (p < 0.05). The difference was not statistically relevant in the control and
scaffold rhBMP-2 treatment group (p > 0.05).
The statistical analysis of results obtained from the computed tomography (CT)
with angiography of the 6-month treatment groups revealed that defect density
measured differed significantly between the scaffold containing treatment groups
and the control (p < 0.05). The results were however not significantly different
between the treatment groups containing scaffolds (p > 0.05) (Figure 4-12, Table
4-5). The density of the newly formed bone and the number of newly formed vessel
branches within the defect did not differ significantly between the treatment groups
(p > 0.05) (Figure 4-4, Table 4-5). The number of vessels contacting the implant
did not differ significantly between the scaffold containing treatment groups
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containing (p > 0.05) (Table 4-5). The contrast enhancement ratio did not differ
significantly between the treatment groups (p > 0.05) (Table 4-5). Further analysis
revealed that the cortical density of the proximal and distal bone fragment was
significantly different between the operated limbs and non-operated in all treatment
groups (p < 0.05). The muscle mass of the gluteal muscle group was significantly
different in the non-operated limb as compared with the operated limb in the
scaffold and scaffold cMSC treatment group (p < 0.05). The difference was not
statistically relevant in the control and scaffold rhBMP-2 treatment group (p > 0.05).
Histology
The specimens harvested from the controls differed significantly in the
macroscopic as well as the microscopic view from the scaffold containing
treatment groups, similarly, among decalcified and undecalcified specimens. The
controls involved only the proximal and distal bone segment as the newly formed
bone did not bridge the defect in the controls (Figure 4-13). Furthermore, the
medullar cavities of the proximal and distal sections were enclosed with the cortical
bone consistent with early non-union changes. Bone segments treated with
scaffolds had osseointegration of the scaffold ends within the medullary cavity. The
ends of the bone segment remained open with new bone formation extending
within the scaffold and growing on the surface of the implants. New bone on-growth
along the surface of the scaffolds had extensive non-mineralized tissue containing
high concentrations of collagen (osteoid) (Figures 4-13 and 4-14). The osteoid was
well-formed within the pores and channels of the scaffolds, and it was equally
distributed within all the sections of the implant. In the tissues harvested from 2month goats, the osteoid appeared more mineralized in the proximal and distal
third of the scaffold and less within the center of the scaffold. This trend was less
noticeable, as the osteoid mineralization was equally distributed across the
specimen (Figure 4-14). The cortical bone was well integrated with the osteoid and
newly synthesized cortical bone surrounding the implant. The periosteum
presented a continuous extension from the proximal and distal bone segment to
the newly formed bone and osteoid surrounding the implant. The unstained slides
revealed a higher level of fluorescence which corresponded with higher bone
metabolic rate in the specimens with lower mineralization, confirming that the bone
formation in those specimens was more active as compared with the tissues
already containing higher mineralization (Figure 4-15). The medullar cavity in all
the specimens was filled with adipose tissue. The large polynuclear cells were not
found in the transition zones between the bone segments and the scaffolds.
Quantitative assessment of the scaffold treated specimens, harvested at 2 and 6
months after surgery, did not reveal statistically significant differences between the
treatment groups in the bone content in the proximal and distal sections as well as
in the osteoid content in the middle sections (p > 0.05) (Table 4-6). There were no
statistically relevant differences in the bone content and in the osteoid content
between the 2- and 6-months goat treatment groups. (p > 0.05).
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VEGF and BMP-2 concentration measurement
The results of the VEGF concentration analysis were not significantly different
between treatment groups at any of the blood collection time points. Furthermore,
the analysis did not reveal a significant linear change in the VEGF concentration
within the treatment groups (Figure 4-7). The VEGF concentration increased from
the baseline concentration over 10 days after surgery and then gradually
decreased to the values before surgery, except in the control group (Figrue 4-7).
The results of the rhBMP-2 concentration analysis revealed a significant linear
increase of the rhBMP-2 concentration within the first month after the surgery
among all treatment groups (Figure 4-8). The increase was noticed to be most
dynamic in the treatment group containing the scaffold soaked in rhBMP-2 (2-fold
of the baseline), followed by the treatment group with the scaffold coated with
cMSC, scaffold only and the negative control. The rhBMP-2 concentration was
significantly higher in the treatment group containing the scaffold soaked with
rhBMP-2 10 and 30 days after the surgery as compared to the control and control
and scaffold coated with cMSC respectively (Figure 4-8).
Discussion
The study showed promising results in bone regeneration using a novel technology
3D nHA-PU-DBP bone scaffold, and therefore the first hypothesis (H1) of the study
was accepted. The bone regeneration was however not associated with the
macroscopic appearance of the neovascularization process. The second
hypothesis (H2) that the bone scaffold will stimulate the neovascularization was
therefore rejected. Similarly, the third (H3) and fourth hypothesis (H4) that there
will be a significant difference in the bone regeneration and neovascularization
between the treatment groups containing scaffolds were rejected. Another
outcome of this study revealed that the concentration of the bone morphogenetic
protein – 2 increased in the linear fashion among all treatment groups.
Furthermore, the highest increase of this growth factor was noticed in the scaffold
rhBMP-2 treatment group which was associated with the gradual release of
rhBMP-2 from the scaffold.
The bone scaffold significantly enhanced tissue regeneration in the scaffold
containing treatment groups. This was constant among the outcomes of all
assessment tools used in this study. The intervals of radiographs and DXA scans
performed in the study were established accordingly to the previous reports using
similar bone healing models, to most accurately detect the changes in the defect
filling with the new bone (40,49-53). The bone healing was found to be significantly
more dynamic within the scaffold cMSC treatment group. 2 goats assigned to this
treatment group bridged the defect completely with a new bone. The defects
healed in all goats in the same manner showing the most dynamic bone healing
adjacent to the stainless-steel locking plate implant which has been already shown
to be osteoconductive (35,54). Only the scaffold containing treatment groups
showed significant bone formation in the center of the defect as well as between
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the far cortices, surrounding the scaffold and justifying the osteoconductive
properties of the utilized implant (35). The bone and osteoid formation occurred in
the same manner among all the treatment groups growing within the implant
equally from the proximal and distal segment of the bone towards the center. The
radiography and DXA showed the most dynamic bone formation within the second
and third month after surgery. Interestingly, the DXA revealed the most dynamic
increase in BMD in the defect during the second month after surgery and the
radiography showed the most dynamic defect reduction within the third month after
surgery and thus one month after the BMD increase. In other words, the healing
process started with the osteoid formation within the pores and interconnected
channels of the implant and this was followed by the bone on growth on its surface
what relates to the osteoinductive properties of the implant (35). The defect
reduction plateaued gradually within the fourth, fifth and sixth months after surgery.
The neovascularization is one of the most important processes in bone
regeneration, as it provides oxygen and nutrients to the regenerating bone tissue
(12-16). The angiogenesis in the regenerating bone occurs due to the enhanced
mobilization of the bone marrow-derived endothelial progenitor cells (EPCs) and
the new vasculature determines the architecture and quality of newly formed bone
(15,16,55). The study did not find statistically significant differences in the number
of newly formed vessel branches and branches contacting the scaffold between
all the treatment groups. A trend was noticed however that the numbers were
higher 2 months after the surgery as compared with the scans taken 6 months after
the surgery. This can be explained by the fact that the neovascularization process
has been found to be most dynamic during the early phases of bone regeneration
(14). The lack of the statistically and clinically significant differences may be
associated with the fact that the used CT machine was not sensitive enough to
detect the microvasculature (50 µm – 500 µm) around the scaffold as well as within
the scaffold. Because of the size of a goat limb, the utilization of a micro-CT to
detect the microvessels was not possible. This study addressed this issue
estimating the contrast enhancement ratio which was directly associated with the
contrast concentration within the defect vasculature. In brief, the analysis of the
contrast enhancement ratio, however, did not show a difference between the
treatment groups. Summarizing, even though neither the scaffold nor the cMSC
nor the BMP-2 significantly influenced the macro vasculature and the contrast
concentration within the defect, they still could have had an influence on the
microvasculature formation and architecture. Because of the above-mentioned
limitations, the study findings regarding the neovascularization should be
interpreted with caution.
The bone marrow-derived allogeneic caprine mesenchymal stem cells (cMSCs)
had a significant positive impact on bone healing. The defects in 2 goats (6.5 cm
and 7.2 cm) which were assigned to the scaffold cMSC treatment group bridged
the defect entirely over 6 months after surgery. The mesenchymal stem cells have
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been already proven to have bone regenerative capacity (31,32,46,52), however,
because of the relatively small number of the goats with such outstanding results,
the bone regeneration in those 2 cases was rather due to the cMSCs interaction
with the host progenitor cells and not due to the pure benefit of the allogeneic
cMSCs. The bone regeneration occurred in the scaffold rhBMP-2 treatment group
was on the other hand not significantly different than that which occurred in the
scaffold only treatment group, even though the rhBMP-2 has been also already
proven to have a stimulative effect on osteogenic differentiation of both
mesenchymal stem cells and osteoblasts (33,56,57). This may be related to the
dose of E-BMP-2 used in this study which was 3 mg per scaffold (approximately in
the concentration of 0.5 mg/cm3) or to the other factors influencing bone
regeneration in such large segmental defects (51,58-60). Furthermore, the
stimulative effect of BMP2 on angiogenesis has been already described in the
literature as well (61-63).BMP2 is known to stimulate migration and tube formation
of human endothelial cells (61-63).
The peripheral blood vascular endothelial growth factor (VEGF) concentration
analysis revealed no differences between treatment groups and no significant
linear changes within 30 days after surgery. There was however an increase in
VEGF concentration from the baseline concentration within the immediate
postoperative period. The positive association between the VEGF concentration in
the local tissues and bone regeneration has been already established in the
literature (48,63-66). Increased secretion of VEGF has been found in osteoblasts
during bone repair as well as in peripheral blood lymphocytes and platelets in
patients with colorectal cancer (48,67). This study, however, did not find significant
differences between the treatment groups in the peripheral blood VEGF
concentration. This may be associated with the fact that the concentration
oscillations correlated with a different pace of bone healing were very low in
peripheral blood and hard to detect or that the size of defect influenced the
concentration more than the pace of tissue regeneration. The analysis of
peripheral blood BMP-2 concentration, on the other hand, revealed a significant
linear increase in this growth factor in the peripheral blood within the 30 days of
defect healing in all treatment groups. The increase was significantly higher in the
scaffold BMP-2 treatment group as compared with the remaining groups, which
was associated with the gradual release of BMP-2 from the implant.
The bone scaffolds were made from biocompatible polyurethane (D3 PU) platform
which was coated with nano-hydroxyapatite (nHA) (25,26). The scaffold
architecture consisted of multiple PU-nHA platforms that were laid on each other
and the decellularized bone particles (DBPs) which were placed in between the
platforms. The PU used in this study is biologically stable for up to 30 days after
implantation (25,26). The PU/nHA ratio is vital for optimal bone regeneration and
it has been previously optimized, and it equaled 80 PU to 20 nHA (25,26). The
porosity, as well as the pore size of manufactured implants, were within the optimal
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range for bone regeneration. The polyurethanes have been previously employed
in multiple biomedical devices (11,17-24) and recently they have gained an interest
in the research due to the significant number of mechanical and biological
advantages which allow them to be incorporated in the bone scaffolds.
Furthermore, depending on the synthesis method, the porosity of synthetized PU
can be controlled in a feasible way (11). They are an excellent candidate to serve
as a platform for the bioactive nanomaterials including nano-Hydroxyapatite in the
bone scaffolds (22-23). Nanostructured hydroxyapatite promotes fibroblastic cell
(a model cell line) and osteoblastic cell (bone-forming cell) adhesion and
proliferation, osseointegration, and the deposition of calcium-containing minerals
on the surface of these materials (68-70). The rough surfaces of nHA are found to
cause asymmetrical division of stem cells into osteoblasts which are also important
for osteoinduction (70). The nanomaterials can alter the surface energy of
materials to control initial protein adsorption and confirmation to inhibit
inflammatory cell functions and promote tissue forming cell functions (71). The
scaffolds coated with nano-HA have been known to improve the mechanical
properties, including increased compressive strength (maximum 0.45 versus to
0.16 MPa for no coating) and elastic modulus (maximum 1.43 versus 0.79 for no
coating) (11,72,73). The final advantage of nano Ha is a porous structure with a
high-binding affinity makes it an excellent drug delivery device and the low
solubility of nano-HA under physiologic condition contributes to its longer
degradation rate and allows the drug delivery in a more controlled manner (70,7478). Therefore, the nHAP particles have been shown to be excellent carriers of
antibiotics (75), anticancer drugs (76), growth factor (77) and enzymes (77,78) for
its notorious adsorption ability.
We encountered several complications while conducting this study, including
orthopedic locking plate bending, excessive periosteal reaction, plate pullout from
the proximal bone segment, fractures of the proximal and distal bone segments as
well as surgery side infections. The scaffold migration after implantation was
observed within 24 hours post-implantation and in all cases, the implant migrated
caudally at its insertion into the distal segment of the tibia. The study utilized a not
commonly used in the research large segmental (up to 7 cm) and full-thickness
tibial defect and some amount of above-mentioned complications were to be
expected. The most common complications included the orthopedic plate bending
and excessive periosteal and endosteal reaction. Neither of them was associated
with the weight of the goat or with the size of the defect (Table 4-7). In the authors’
subjective opinion, the goats which encountered plate bending showed a higher
level of activity in the postoperative period. This was however not assessed in an
objective manner. The excessive periosteal and endosteal reactions occurred in
both cortices around the screw implants and could have resulted from an instability
in the plate-screw constructs. The further complications including fractures and
infections occurred in the goats with a higher size of the defect (above 7 cm) and
it can be therefore concluded that they were related to the size of the defect and
the size of the remaining bone segments. The rate of infections was higher in those
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goats because of a higher amount of created dead space after the segment
removal. All the complications occurred within the first and second months after
the surgery. The overall survival rate in this study was calculated at 91% (61/67
goats).
Conclusions
Bone scaffolds not only provided the surface for the bone on growth
(osteoconduction) but also stimulated the bone ingrowth within the implant
(osteoinduction) as well as around the implant (osseointegration) as compared
with the negative controls. Furthermore, the tested bone scaffolds were excellent
delivery devices for the bioactive agents such as the human recombinant bone
morphogenetic protein-2 and caprine mesenchymal stem cells which significantly
stimulated and enhanced bone regeneration. Neither the scaffolds, scaffolds with
rhBMP-2, nor scaffolds with cMSC improved the macro angiogenesis in the
regenerating bone. However, their influence on the microvasculature formation
remains unknown. Furthermore, the bone scaffolds used in this study did not cause
excessive inflammatory processes within the healing defects as compared to the
control defects. The animal model with such a magnitude of the tibial segmental
defect (> 6 cm) has been successful as the bone regeneration model with a high
survival rate and relatively low complication rate.
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Tables

Table 4-1. Radiographical ostectomy gap scoring.

Ostectomy Gap Filling
Score
0
1
2
3

Ostectomy gap filling
No interval change compared to immediate post-operative radiographs
New bone filling <25% of ostectomy gap
New bone filling 26-50% of ostectomy gap
New bone filling 51-99% of ostectomy gap
Ostectomy gap completely filled and/or bridging callus present on at
4 least 3 cortices

Table 4-2. Radiographical opacity of new bone scoring.

Opacity of new bone
Score
0
1
2

Opacity of new bone
No interval change compared to immediate post-operative radiographs
New bone less opaque than normal cortex
New bone of similar or greater opacity compared to normal cortex
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Table 4-3. Radiographic defect size evaluation.

Defect Reduction
Time point
After 2 Months Post OP
After 6 Months Post OP
Tx Group Line
Line
Line Average Line Line
Line Average
1
2
3
(mm)
1
2
3
(mm)
(mm) (mm) (mm)
(mm) (mm) (mm)
Control 2.8
4.9
2.1
3.3
19.5
8.1
2.0
9.9
±5.1
±8.1
±2.8
±5.5
±18. ±7.5
±4.1
±13.4
6
Scaffold 5.8
5.5
3.3
4.9
20.0 13.2
9.4
14.2
±6.8
±2.1
±3.1
±4.3
±11. ±3.8
±5.5
±8.7
9
Scaffold + 2.7
2.6
-2.1
1.1
27.0 14.5
6.6
16.1
rhBMP-2 ±4.8
±2.9
±2.4
±3.9
±9.1 ±2.5
±2.9
±10.2
Scaffold + 4.1
3.7
4.4
4.1
43.5 41.9 36.8
40.8
cMSC ±3.1
±1.9
±5.2
±3.4
±36. ±40. ±37.0
±34.5
2
6
Total 3.8
4.2
1.9
3.3
27.5 19.4 13.7
20.2
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Table 4-4. BMD results comparison.

BMD (g/cm2) Comparison Table
Tx
Group
Control
Scaffold
Scaffold
+ BMP2
Scaffold
+ cMSC

2 Months
D0
0.00
±0.0
0.29
±0.0
0.27
±0.0
0.27
±0.0

M1
0.01
±0.0
0.42
±0.1
0.41
±0.1
0.42
±0.1

6 Months

M2
0.07
±0.1
0.51
±0.1
0.51
±0.1
0.56
±0.2

D0
0.00
±0.0
0.38
±0.1
0.31
±0.0
0.27
±0.0

M1
0.00
±0.0
0.47
±0.0
0.45
±0.0
0.43
±0.1

M2
0.01
±0.0
0.56
±0.0
0.52
±0.0
0.64
±0.2

M3
0.05
±0.1
0.58
±0.0
0.53
±0.1
0.68
±0.3

M4
0.07
±0.1
0.53
±0.1
0.49
±0.1
0.75
±0.3

M5
0.05
±0.1
0.48
±0.1
0.45
±0.1
0.80
±0.4

M6
0.07
±0.1
0.46
±0.1
0.40
±0.1
0.80
±0.5

Table 4-5. CT Evaluation

2 Months Post OP
Density of
defect/graft
(HU)

Treatment
Group
Control
Scaffold
Scaffold +
rhBMB2
Scaffold +
cMSC
Control

Density of
new bone
Scaffold
(HU)

Scaffold +
rhBMB2
Scaffold +
cMSC

Mean

6 Months Post OP

40.71
857.00
803.88

Std
Dev
±4.07
±75.35
±83.36

833.83

±73.96

930.00

±274.66

665.33

±229.80

1200.60

±201.09

809.00

±243.30

1170.17

±190.56

790.50

±64.35

1288.20

±254.70
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Sig
0.00

0.57

Mean

Std Dev

Sig

28.86
777.67
625.86

±21.63
±128.47
±121.84

0.00

812.50

±310.96

1050.80

±347.40
0.53

Table 4-5. CT Evaluation (Continuation)

Number of
vessel
branches

Number of
vessels
contacting
the graft

Defect
density pre
contrast (HU)

Defect
density post
contrast (HU)

Contrast
Enhancement
Ratio

2 Months Post OP
Treatment
Mean
Group
Control
28.14
Scaffold
40.71
Scaffold +
32.50
rhBMB2
Scaffold +
30.00
cMSC
Control
0.00
Scaffold
9.43
Scaffold +
8.13
rhBMB2
Scaffold +
8.17
cMSC
Control
222.43
Scaffold
253.00
Scaffold +
236.25
rhBMB2
Scaffold +
262.67
cMSC
Control
255.43
Scaffold
310.57
Scaffold +
269.13
rhBMB2
Scaffold +
287.67
cMSC
Control
1.15
Scaffold
1.23
Scaffold +
1.14
rhBMB2
Scaffold +
1.10
cMSC

Std
Dev
±11.35
±12.51
±21.17

Sig

21.29

±7.78

±11.37

23.00

±17.44

±0.00
±4.16

0.00
4.56

±0.00
±2.46

5.43

±2.70

4.63

±4.34

±4.45

0.44

6 Months Post OP
Std
Mean
Sig
Dev
14.86
±2.91
23.56 ±12.00

0.00

±3.97
±36.64
±48.85
±43.62

0.33

215.86 ±56.76
215.25 ±42.91

±42.30
±62.87

158.71 ±48.84
228.44 ±47.29
0.20

±33.97

±0.03
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248.14 ±52.27

0.03

0.01

247.75 ±54.82

±0.10
±0.08
±0.07

0.01

136.71 ±50.39
200.33 ±62.38

±35.88

±51.06

0.47

0.03

1.19
1.18

±0.12
±0.16

1.17

±0.09

1.15

±0.08

0.91

Table 4-6. Bone and osteoid formation.

Control
Prox
Middle
Dist

Prox
Middle
Dist

50.7
±18.9
0.0
±0.0
63.2
±10.7
57.1
±15.6
0.0
±0.0
58.4
±12.1

(%) 2 - Month Treatment Groups
Scaffold
Scaffold
rhBMP-2
46.9
47.9
±11.7
±15.4
43.0
38.5
±10.7
±17.9
51.0
58.2
±12.7
±12.0
(%) 6 - Month Treatment Groups
43.8
44.8
±13.8
±7.9
43.7
44.8
±9.7
±16.6
40.1
50.1
±10.1
±18.4

Scaffold
cMSC
50.2
±9.2
45.3
±3.8
52.4
±5.5
50.3
±13.5
50.2
±12.5
48.5
±9.9

Table 4-7. Complications.

Complication
No of goats
% of goats
Average
Defect Size
Average
Weight

Number of complications
0
1
2
3
61.0
17.0
11.0
4.0
100.0
28.0
18.0
6.6
6.6
6.7
6.2
5.3
±1.4
±1.4
±1.5
±1.6
55.6
55.4
54.1
57.0
±7.9
±8.9
±9.2
±5.3

4
3.0
4.5
7.4
±0.4
40.7
±4.7

5
4.0
6.6
7.1
±1.7
50.3
±5.7

Complication description: 0 – study population, 1 – orthopedic plate bending, 2 –
excessive periosteal reaction, 3 – scaffold migration, 4 – deep infection, 5 – split
fracture of the bone fragment.
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Figures

Figure 4-1. Survival Kaplan-Meier curve.
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Figure 4-2. Thermography curve.
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Figure 4-3. Radiographical assessment.
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Figure 4-4. Defect reduction after surgery.

Figure 4-5. BMD comparison at termination points.
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Figure 4-6. BMD curve.

Figure 4-7. Peripheral VEGF curve.
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Figure 4-8. Peripheral BMP2 curve.
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Figure 4-9. Defect Comparison.
The comparison of defects assigned to different treatment groups, 2 months after
surgery (A) and 6 months after surgery (B). The treatment groups in both time
points from the left side, control, scaffold, scaffold rhBMP2, and scaffold cMSC.
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Figure 4-10. Representative defect cMSC healing.
The sequential monthly radiographic evaluation of the representative defect of ana
goat assigned to the 6 months scaffold cMSC group. The images are organized
from left side in following order - day 1 after the surgery, 1 month, 2 months, 3
months, 4 months, 5 months and 6 months after the surgery.
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Figure 4-11. Defect measurements.
Defect measurements in goat assigned to the 6 months scaffold only treatment
group. The first image on left side shows defect 1 month after surgery, image in
the middle shows the defect 3 months after surgery and the last image from left
side shows the defect 6 months after the surgery. The defects were measured in
3 different lines and all three different lines were analyzed separately.
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Figure 4-12. 3D CT reconstruction.
Representative image of Computed Tomography – Angiography. Osteotomy limbs
were directed towards outside of this image. Note, increased density of vasculature
after the surgery as well as new vessel branches entering the scaffold from
proximal side. This goat was assigned to the 6-month study time point, scaffold
cMSC treatment group.
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Figure 4-13. 2-month goats histology.
Tissues harvested from goats assigned to the 2-month time point. Presented
specimens have been stained according to the Masson’s trichrome protocol. The
red color is associated with mineralized tissue whereas blue color is associated
with non-mineralized tissue. Mineralized tissue has been defined as bone and nonmineralized tissue as osteoid. Tissues have been divided into proximal, middle and
distal sections. The figure contains representative images of, beginning from left,
control, scaffold, scaffold with rhBMP2 and scaffolds with cMSC respectively.
Difference in bone content was not found to be statistically significant between
treatment groups, as well as difference in osteoid within scaffold was not found to
be significant between treatment groups.
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Figure 4-14. 6-month goats histology.
Tissues harvested from goats assigned to the 6-month time point. Specimens were
harvested in their entirety and processed undecalcified. Presented specimens
were stained accordingly to von Kossa protocol. The mineralized tissue with high
calcium concentration stained black, whereas the non-mineralized tissue stained
blue. The figure shows representative specimens of three treatment groups,
beginning from left, scaffold, scaffold with rhBMP2, and scaffold with cMSC
respectively. Histology images are directly compared with their respective CT
images.
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Figure 4-15. Fluorescence of 6-month specimens.
Tissues harvested from goats assigned to the 6-month time point. The images in
the top row were left unstained to evaluate fluorescence associated with
metabolically active bone and images in bottom row were stained accordingly to
Goldner’s trichrome protocol. It was noticed that the specimens with tissue
containing a higher amount of non-mineralized tissue (red stain in Goldner’s)
presented higher fluorescence as compared with the specimens containing a
higher amount of mineralized tissue (green stain in Goldner’s). The figure presents
unstained slides of tissues harvested from three different treatment groups,
beginning from left, scaffold, scaffold with rhBMP2, and scaffold with cMSC with
their respective Goldner’s images.
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ANOVA – Analysis of Variance
BMD – Bone Mineral Density
BMP2 – Bone Morphogenetic Protein-2
rhBMP2 – human recombinant Bone Morphogenetic Protein-2
cMSC – caprine Mesenchymal Stem Cells
CT – Computed Tomography
DBP – Decellularized Bone Particles
DMEM - Dulbecco’s Modified Eagle Medium
DICOM – Digital Imaging and Communications
DXA – Dual X-ray Absorptiometry
HBSS – Hanks Balanced Salt Solution
HU – Hounsfield Units
nHA – nanophase Hydroxyapatite
PACS – Picture Archival and Communication System
PU – Polyurethane
ROI – Region of Interest
TRAP – Tartrate-resistant acid phosphatase
VEGF – Vascular Endothelial Growth Factor
VVG – Verhoeff-Van Gieson
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Recombinant human bone morphogenetic protein – 2, SBH Sciences Inc,
Natick, MA
T175 tissue culture flask, Fisher Scientific, Hampton, NH
Hank’s Balanced Salt Solution, 500 ml, HyClone Laboratories, Logan, UT
Dulbecco’s Modified Eagle Medium with glutamine, HEPES buffer,
pyruvate, HyClone Laboratories, Logan, UT
Fetal bovine serum, Life Technologies, Eugene, OR
Penicillin, HyClone Laboratories, Logan, UT
Streptomycin, HyClone Laboratories, Logan, UT
Trypsin, Trypsin 0.25% 1x, HyClone Laboratories, Logan, UT
Dimethyl sulfoxide, Hybri-Max, Milipore-Sigma, St. Louis, MO
Liquid Nitrogen, HyClone Laboratories, Logan, UT
Ceftiofur sodium, 1g powder, Naxcel, Zoetis, Parsippany-Troy Hills, NJ
Flunixin meglumine, 50mg/ml, Prevail, VetOne®, Boise, ID
Xylazine hydrochloride, Xylamed, 20 mg/ml, VetOne®, Boise, ID
Ketamine hydrochloride, Zetamine, 100 mg/ml, VetOne®, Boise, ID
Midazolam, 5 mg/ml, Akorn, Ann Arbor, MI
Isoflurane, 250 ml, VetOne®, Boise, ID
Oscillating bone saw,
8-hole 4.5 mm locking plate, Veterinary Orthopedic Implants, St.
Augustine, FL
4.0 locking head screws, Veterinary Orthopedic Implants, St. Augustine,
FL
Gentamicin sulfate,100mg/ml, VetOne®, Boise, ID
PDS II - Polydioxanone #2-0 (3.0 metric) suture with CT-1 36 mm 1/2c
taper needle, Ethicon, Guaynabo, Puerto Rico
SurgiproTM – Polypropylene monofilament #0 (3.5 metric) suture with C17 39 mm 3/8 cutting needle, Covidien, Mansfield, MA
Fluke VT04A Visual IR Thermometer, Fluke Corporation, Everett, WA
Portable radiography machine, Philips Easy Diagnost RF System, Philips
International B.V., Amsterdam, Netherlands
Digital radiography plates (CXDI-50G), Canon USA, Inc., Melville, NY
NEXT Equine DR™ EDR6, Sound - Eklin®, Sound Technologies,
Carlsbad, CA
PACS system, Spectra PACS IDS7, Spectra AB, Linkoeping, Sweden
Dual X-ray Absorptiometry system, QDR 4500 Hologic Inc.
CT scanner, Philips Brilliance-40, Philips International B.V., Amsterdam,
Netherlands
OptirayTM 350, Mallinckrodt Inc, Hazelwood, MO
Oxytetracycline, 200 mg/ml, Liquamycin®, Zoetis, Parsippany-Troy Hills,
NJ
Decalcifying solution protocol A, Fisher Scientific, Hampton, NH
Decalcifying solution protocol B, Fisher Scientific, Hampton, NH
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hh.
ii.
jj.
kk.
ll.
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PMMA, Sigma-Aldrich, Histological Grade, St. Louis, MO
Automated tissue processor, ASP300S, Leica, Germany
Fiji, ImageJ, National Institute of Mental Health, Bethesda, Maryland
BMP2 ELISA kit, ABclonal, Woburn, MA
VEGF ELISA kit, ABclonal, Woburn, MA
IBM® SPSS Statistics™ v.25 Software, IBM, New York, NY
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CHAPTER FIVE
EFFECTS OF NOVEL 3D BONE SCAFFOLD ON THE HEALING
OF EQUINE IV METACARPAL BONES.
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Abstract
Background
Bone regeneration remains a challenge in horses. Scenarios in which horses may
benefit from enhanced bone healing include comminuted fractures, subchondral
bone cysts, osteoarthritis and bone infections. This study aimed to assess bone
regenerative capacity of a nano Hydroxyapatite polyurethane bone scaffold. The
scaffolds were evaluated in five horses. Study design included 10 splint-bone
defects assigned to scaffold (n=5) and control treatment group (n=5). Two cm fullthickness defects were created in both fourth metacarpal bones in each horse.
Bone healing assessment conducted over the ensuing 60 days included high
definition infrared thermography camera, ultrasonography, radiography, and
computed tomography. Histological evaluation of the tissue filling each defect was
conducted at the termination of the study.
Results
The analysis of radiography revealed a significantly higher percentage of new bone
formation (67.42% of the defect size) within defects containing bone scaffold as
compared to defects left unfilled (35.88% of the defect size). Further analysis of
computed tomography images revealed that defects containing bone scaffold had
a significantly higher density as compared to the control (807.80 HU and 464.80
HU in defects with bone scaffold and control respectively). Neither ultrasound nor
thermography revealed signs of adverse effects associated with bone scaffold
implantation. Histological evaluation confirmed significant bone formation within
the pores and channels as well as on the surface of the bone scaffold.
Conclusions
The novel bone scaffold technology showed to be osseointegrative in current
research model. The implant can be utilized to enhance the bone regeneration in
horses affected by subchondral bone cysts, comminuted fractures with bone loss
or in horses requiring arthrodesis. The unique design and composition of the
implant allows for potential use as a drug delivery device.
Introduction
Bone injuries resulting in tissue loss and mechanical impairment are common in
equine athletes. Examples include fractures (1-4), subchondral bone cysts (5-10),
and bone infection (11-14). Fractures have been estimated to cause up to 63% of
fatal injuries in the racing industry (1-3) and approximately 34% of them are
comminuted with a variable degree of bone loss (2,4). Bone regeneration remains
challenging in equids due to delayed or poor healing, repair failures resulting from
high-stress loads, and infection (11-14). Prolonged convalescence is further
associated with life-threatening complications, such as contralateral limb laminitis
or colitis caused by an extended course of medication (15,16).
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To date, autologous cancellous bone graft (autograft) is the gold standard to fill in
the void in bone because of the low rejection risk as well as high osteoprogenitor
cell concentration (17,18). Limitations of autografts include the necessity of a
second surgery site, increased risk of infection, and a limited amount of donor
tissue available (19,20). Because of the limitations, an ideal substitute for an
autograft is desirable. It should be osteoinductive, osteoconductive and
osseointegrative (21). Several allogenic materials have been tested in horses; they
are however lacking three-dimensional structure and adequate mechanical
properties (22-25)
The objective of this study was to evaluate regenerative capacity of a threedimensional hydrophilic polyurethane platform coated with hydroxyapatite
nanoparticles (nHA) and decellularized bone particles (DBP) (26). Hydrophilic
polyurethane (PU) is a biocompatible synthetic polymer with stable biological and
mechanical properties (26). Nanostructured hydroxyapatite has been shown to
promote fibroblastic and osteoblastic cell adhesion and proliferation
(osteoinduction and osteoconduction), provide calcium-containing minerals, and
change the energy of coated materials to control initial protein adsorption as well
as change the conformation to inhibit inflammatory cell functions (27-31).
The bone scaffold was evaluated in defects that were created in the fourth
metacarpal bones of horses. This has been established as an acceptable model
of equine bone healing (22,32-38). The hypothesis was that the bone scaffold will
be osteoinudctive, osteoconductive and osseointegrated, and therefore will
enhance bone regeneration within the implanted defects as compared to the
contralateral non-implanted control.
Materials and Methods
Study Population and Study Design
The study was conducted on mares acquired for this study from local vendors and
owned by the University of Tennessee, College of Veterinary Medicine (UTCVM).
The study was approved by the University of Tennessee Institutional Animal Care
and Use Committee and was conducted according to the IACUC protocol #26090518. Horses were screened for general health as well as orthopedic conditions.
Horses which showed signs of systemic diseases (e.g. bronchitis, pneumonia,
chronic weight loss, colitis, etc.), were lame or had palpable abnormalities the
fourth metacarpal (MC IV) bones, were not included in the study. The fourth
metacarpal bones of each horse were randomly assigned to one of two treatment
groups, S – bone scaffolda (n=5) and C – control (n=5).
Study Timeline
Horses were quarantined 14 days prior to the study. Each horse was transported
from the farm to the veterinary teaching hospital 48 hours before the scheduled
surgery. The surgeries were performed on day 0 followed by 5 days of
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postoperative care which involved physical examinations and perioperative
medications. The horses' activity was restricted to stall rest for 14 days after
surgery so as not to compromise surgical site healing and to prevent bone scaffold a
displacement. After 14 days, sutures were removed, and the horses were allowed
access to small runs in front of the stalls for an additional 14 days. Forelimbs were
kept bandaged for 21 days following the surgery after which the wounds were
covered with standing wrap bandages for another 9 days. Thirty days after surgery,
the horses were turned out on pasture for an additional 30 days before tissue
biopsy was performed.
Bone scaffold implantation surgery
Perioperative treatment included gentamicin sulfate b (6.6 mg/kg IV, q24h),
penicillin procaine Gc (22,000 IU/kg IM, q12h), and a non-steroidal antiinflammatory – firocoxibd (0.3 mg/kg IV, q24h). The horses were sedated with
acetylpromazine maleate (0.04 mg/kg IM) followed approximately 30 min later by
xylazine hydrochloridee (1.0 mg/kg IV). Anesthesia was induced with ketamine
hydrochloridef (2.2 mg/kg, IV) and midazolamg (0.05 mg/kg, IV). Anesthesia was
maintained with isofluraneh in oxygen (3 L/min) and xylazine hydrochloride e (1
mg/kg/h). Horses were placed in dorsal recumbency and both forelimbs were
clipped from the hoof to above the carpus. The surgical site was aseptically
scrubbed and draped for aseptic surgery. A 5 cm long incision was created over
the middle third of the left MCIV. Subcutaneous tissue was bluntly separated to
expose the bone. A 2 cm long fragment of the MCIV was removed using an
oscillating bone saw. Care was taken not to injure the underlying suspensory
ligament during the procedure. The created defect was either filled with bone
scaffolda or left unfilled according to the treatment group assignment. Prior to
implantation, the bone scaffoldsa were soaked in 1 ml of sterile saline to allow the
implant to absorb the fluid and increase its volume (Figure 5-1, all figures and
tables are placed in the appendix). Subcutaneous tissue was closed in a simple
continuous pattern using absorbable suture i and skin was closed in the simple
continuous pattern using non-absorbable suturej. Surgery on the right MCIV was
performed in the same manner as on the left MCIV. Sterile wraps were temporarily
placed on both forelimbs and CT was performed to establish the baseline of defect
density. Following CT, sterile distal limb bandages were placed, and the horse was
allowed to recover from general anesthesia. Antibiotics as previously described
were administered for an additional 48 hours. NSAID's as previously described
were administered for an additional 72 hours.
Data acquisition throughout the study
The amount of postoperative inflammation surrounding the implant, including soft
tissue swelling and local fluid accumulation, was assessed with ultrasonography
and thermography. Thermographyk was recorded in degrees Celsius (°C) by the
same investigator (RG) in two projections, anteroposterior and lateral-medial
projection, maintaining the same distance (0.5 m) during each recording. The
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camera was adjusted to the environmental temperature and humidity and the
recording was performed 5 min after bandage removal to allow the limb to cool
down. Thermography was performed on the days 1, 3, 5,7,10,14,21,30 and 59
following surgery. One 45° dorsolateral-palmaromedial oblique (DLPMO)
projection of each MC IV bone was recorded using a portable radiograph machine l
on standing horses day 1 (Figure 5-2) after surgery followed by day 14, 30 and
59. Ultrasonography was performed by one investigator (RG) using a portable
ultrasound machinem on standing horses day 1 (Figure 5-3) after surgery followed
by day 14, 30 and 59. The CT was carried out using a 40-slice helical CT scannern
immediately after implantation surgery and again 60 days post-implantation
immediately before tissue biopsy (Figure 5-4). Transverse images were
reconstructed in 0.67- and 5-mm slice thickness, and sagittal and dorsal
multiplanar reconstructed (MPR) images were generated. Images were sent to
picture archive and communication systemo. The biopsied tissue was submitted
for histological evaluation.
Data Analysis
The data collected from bone healing assessment was organized in Excel p
spreadsheets. Radiographs and CT images were evaluated by a board-certified
radiologist (SH) and scored for osteotomy gap filling as well as opacity of a new
bone (Tables 5-1 and 5-2). The two individual scores were summarized for an
overall radiographic healing score of each defect. Quantitative assessment of
defect filling with new bone was performed on the radiographs using the NIH Fiji
softwareq by the principal investigator (RG). Quantification was conducted through
the generation of binary masks (black background and white color for bone) for
images and drawing the region of interest (ROI) covering entire defect. The defect
filling was calculated as the amount of white color (bone) within the ROI and
expressed as percent of the defect area. The CT images were scored for new bone
formation (Table 5-3) and the visibility of graft material on the CT images were
recorded as being present or absent. A transverse slab was reconstructed
spanning the length of the defect for both the study and control leg, and density of
the defect was measured quantitatively with the results being expressed in
Hounsfield Units (HU). Ultrasonography images were descriptively evaluated for
any signs of inflammation surrounding the filled or unfilled defects.
Tissue Biopsy
At the termination of the study (60 days post implantation), the horses underwent
CT and tissue biopsy. The perioperative treatment was as previously described.
General anesthesia was induced as previously described. Horses had CT of both
forelimbs performed and then both forelimbs were prepared for aseptic surgery in
the same manner as previously described. A 5 cm long incision was created above
the location of the previously created defect in both forelimbs and subcutaneous
tissue was bluntly separated to present the defect. A 5 mm thick biopsy was
performed at the center of the defect using a scalpel blade or osteotome if required.
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Care was taken not to injure the underlying suspensory ligament during the
procedure. Subcutaneous tissue and skin were closed as previously described.
Sterile distal limb bandages were applied to both forelimbs and the horse was
allowed to recover. Tissue was subsequently submitted for the histological
evaluation. Postoperative care was as previously described.
Histology
Histology was performed on decalcified specimens. Each tissue specimen was
preserved in 10% neutral buffered formalin (NBF)r for 48 h after tissue biopsy and
was then decalcified with 15% formic acid for up to 14 days after tissue harvest.
Specimens were cut with a scalpel and were stained with Hematoxylin and Eosin
(H&E) for histologic evaluation. Histologic sections were analyzed using a light
microscope at 10, 20 and 100 X magnification. The area available for tissue ingrowth was analyzed and described.
Statistical Analysis
The analysis was performed using SPSS statistical softwares and PS power and
sample calculation softwaret. Descriptive statistics were determined for the
continuous variables including thermography, percentage of defect filling as well
as defect density after bone scaffolda implantation and before biopsy. The
normality of data distribution of each variable was performed using a KolmogorovSmirnov test of normality. The variables with continuous data were compared
between the treatment groups using a paired-samples student T-test. The
variables with categorical data were compared between the treatment groups
using the Wilcoxon Signed Ranks test. The statistical significance was assumed
at α = 0.05. The calculated power of the study design and carried out evaluations
to detect the true difference in the filling of the defect with the new bone was β =
0.9.
Results
The study included five adult mares (4 -10 years of age) with a mean weight of
437.7 kg (± 29 kg). The breeds of the horses included Thoroughbred (n=1), Quarter
Horse (n=1), Rocky Mountain Horse (n=1), Standardbred (n=1) and unknown
(n=1). The bone scaffolds, after being soaked in sterile saline, increased by 100%
of its original volume, however, the soaking did not compromise their integrity. The
bone scaffolda remained mechanically tunable and handling, as well as the
implantation process, were accomplished with no damage to bone scaffolda
(Figure 5-1). None of the adverse effects were detected after implantation,
including excessive swelling, seroma formation, or surgical site infection. The
analysis of the high definition infra-red (HD-IR) thermography did not reveal
significant differences between the treatment groups in the temperature of the
superficial tissues over the surgery site immediately after the surgery (p>0.05).
The temperature gradually decreased over 60 days after surgery equally in both
treatment groups (Figure 5-7).
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Radiographically, the defects with bone scaffolds contained a significantly higher
percentage of bone 60 days after the implantation, as compared to controls
[67.42% (±26.7%) in the bone scaffolda group and 35.88% (±32.69%) in the control
group (p=0.013)] (Figure 5-2, Table 5-4). In one of the five horses, the bone
scaffolda was slightly displaced in the proximal aspect, but this did not interfere
with bone formation within the defect. The qualitative assessment of the
radiographs failed to show a statistically significant difference between the
treatment groups (p>0.05). However, the bone scaffolda treatment group showed
a trend of a higher median gap-filling and new bone opacity score as compared to
the control (Figure 5-8). The qualitative assessment of the CT images, including
the amount of newly formed bone within the defect was significantly higher in the
bone scaffolda group as compared with the control group (p=0.038).
Quantitatively, the density of new bone filling the defects in the bone scaffold a
group was significantly higher than that in the control, revealing 807.80 HU
(±129.63 HU) and 464.80 HU (±81.27 HU) respectively (p=0.002) (Figure 5-4 and
Figure 5-9). Fourteen days following the implantation, ultrasonography revealed
mild to moderate homogeneous fluid accumulation around the bone scaffold a and
soft tissue swelling (Figure 5-3). Neither the fluid accumulation nor the soft tissue
swelling was different from that of the defect in the control group. Serial
ultrasonographic evaluation confirmed gradual bone formation around the bone
scaffold, which was evident as a smooth hyperechogenic line at the surface of the
implant (Figure 5-3). Histology confirmed significant bone formation within the
pores and channels of the implant and around the implant (Figure 5-5). Analysis
of the histological slides revealed several cartilage clusters within the bone tissue.
In contrast, the center of the control was filled with connective tissue with no signs
of bone formation (Figure 5-6).
Discussion
The study presented promising results in the enhancement of bone regeneration
using the bone scaffolda in equids. The results were statistically and clinically
significant as well as the calculated power of the study (β=0.9) revealed that 90%
of the outcome was not related to a chance. The surgeries were rapid and scaffold
manipulation as well as implantation was feasible in all cases. The bone scaffolds
absorbed entire 1 ml of sterile saline after being soaked before the surgery. The
fluid absorption increased the size of the implant by approximately 100%, however
this did not compromise its integrity. The proximal aspect of one out of five implants
was mildly displaced within the defect in the abaxial direction, however it did not
interfere the bone healing. None of the horses developed adverse effects
associated with the scaffold implantation.
The defects containing the scaffolds in all 5 horses were filled in with a higher
amount of the new bone as compared to the negative control on the contralateral
limb. The amount of new formed bone varied similarly within the treatment groups
as it was shown with the similar standard deviations. The original hypothesis that
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the bone scaffold is osseointegrative in equids was accepted. These terms mean
that the scaffold did stimulate the primitive, undifferentiated and pluripotent cells to
produce the bone lineage (osteoinduction) as well as attracted the cells to the
material allowing them to produce the bone on its surface (osteoconduction) (21).
Both processes resulted in implants satisfying osseointegration grade which was
associated with the direct formation of bony tissue around the implant without the
layer of fibrous tissue on the implant-bone surface (21).
Up to date, there are several bone scaffolds which have been researched on
horses (22-25). The features of bone scaffold used in this study are unique from
other synthetic scaffolds (26). Most important is related to its hydrophilic structure
which allows for implant swelling and filling non-uniform bone voids and
incongruencies. Further advantage is related to its mechanical integrity. The
combination of soft (PU) and hard components (nHA, DBP) gives it overall
mechanical stability and stiffness greater than that of the individual components.
The scaffold is being implanted into the defect in press-fits matter, and the flow of
blood and cellular components leads to immediate hydration. Unique porosity, with
pore size ranging between 50 and 800 μm and interconnected pore distribution,
implant induces advanced and early neovascularization. is ideal for new bone
formation based on the fact that the small pores facilitate early vascularization, and
the larger ones facilitate larger blood vessel formation – resulting in rapid
vascularization of the graft, which is responsible for fast and reliable new tissue
formation (26).
Horses may benefit from enhanced bone regeneration for several reasons. The
most common include long and flat bone fractures (1-4), subchondral bone cysts
(5-10), bone infections (11-14), and arthrodesis (46-51). Bone regeneration
remains challenging in equids and the fractures have been associated with up to
63% of fatal injuries in the racing industry (1-3). It is not uncommon that the
fractures are open and comminuted (2,4,11-14). The current success rate of
subchondral bone cyst treatment varies between 56-75% in the return to the
previous level of performance (5-10). All the methods described in the literature
are aimed at reducing the inflammation within the cyst as well as filling and
decompressing the bone void (5-10). The rate of surgical site infection following
the long bone fracture repair and arthrodesis has been reduced over the years and
currently reported as 14% in one of the veterinary teaching hospitals (11-14). The
chronic degenerative osteoarthritis often requires arthrodesis which success rate
varies between 46-75% in the return to the previous level of performance (46-51).
In all of these cases, the bone scaffolda used in this study could serve as a bone
filler and enhance bone regeneration, potentially increasing the positive outcome
of the treatment. Additionally, the implant may serve as a drug delivery device in
infected tissue.
This novel technology was tested in the equine splint-bone model, which has been
a well-established model to research bone healing in horses (32-38). The splint140

bone partial ostectomy procedure is considered a safe method with minimal soft
tissue disruption, which does not cause exostosis or sequestration formation (32).
Furthermore, this procedure did not impair the perfusion and integrity of the distal
fragment, which was most likely maintained from the periosteal and soft tissue
vasculature (32). The horses tolerated the procedure well with the lack of
noticeable pain, discomfort, or gait impairment. Because of the thick interosseous
ligament between the fourth and third metacarpal bones, the osteotomies provide
relatively stable, uncomplicated, and appositional bone healing models with the
advantage of not requiring an internal fixator (32-38). Each horse can serve as its
control because of multiple splint bones and therefore reducing the intra-individual
healing variability (35). The limitation of this model is related to the fact that the
fourth and second metacarpal bones are not fully weight-bearing bones as well as
they do not contain a medullar cavity, therefore the entire healing process occurs
from the periosteum. To the best of our knowledge, this is only one full-thickness
long bone healing model described in horses.
Conclusions
The bone scaffold enhanced the splint bone regeneration after 60 days post
implantation in the splint-bone healing model. The results were repeatable among
the horses with relatively small inter-individual variation. Because of the unique
design of this bone regenerative technology the implant can be further used as the
drug delivery device. The future research direction therefore will include delivery
of bioactive agents into the defect, such as commonly used platelet rich plasma
gels (PRP) and mesenchymal stem cells (MSC).
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Tables

Table 5-1. Radiographical ostectomy gap filling scoring system.

Ostectomy Gap Filling
Score Ostectomy gap filling
0 No interval change compared to immediate post-operative radiographs
1 New bone filling <25% of ostectomy gap
2 New bone filling 26-50% of ostectomy gap
3 New bone filling 51-99% of ostectomy gap
4

Ostectomy gap completely filled and/or bridging callus present on at
least 3 cortices

Table 5-2. Radiographical opacity scoring system.

Ostectomy Opacity
Score Opacity of new bone
0 No interval change compared to immediate post-operative radiographs
1 New bone less opaque than normal cortex
2 New bone of similar or greater opacity compared to normal cortex
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Table 5-3. CT ostectomy gap filling scoring system.

CT Ostectomy Gap Filling
Score Ostectomy gap filling
0 No evidence of new bone formation adjacent to graft or within
1
2
3
4

osteotomy gap
New bone filling <25% of ostectomy gap
New bone filling 26-50% of ostectomy gap
New bone filling 51-99% of ostectomy gap
Ostectomy gap completely filled and/or bridging callus present on all
cortices

Table 5-4. Percent of defect filling.

Comparison of defect filling in scaffold and control
No
1
2
3
4
5
Mean
St Dev

Defect filling in scaffold (%)
62.31
27.92
81.59
65.35
99.92
67.42
±26.68
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Defect filling in control (%)
39.01
1.79
31.68
18.37
88.58
35.89
±32.69

Figures

Figure 5-1. Bone scaffold.
The figure presents two images, the image on the left side shows the 2 cm long
bone scaffold and image on the right side shows bone scaffold placed within the
defect created in the fourth metacarpal bone. (c) 2020 Photographs of bone filler
scaffold used with permission of NuShores Biosciences LLC).
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Figure 5-2. Radiographic assessment of healing.
The figure shows a representative sequence of radiographs taken throughout the
study of the defect filled with the bone scaffold (A) and the control (B). The defects
were created in the fourth metacarpal bones in same horse. Each sequence within
the bone scaffold and control treatment group consist of four images which were
recorded at 24h (starting from the left side), 14, 30 and 60 days after the
implantation surgery. This figure shows gradual filling of defects containing bone
scaffold with a new bone (A) as compared to the control, where the bone
regeneration was minimal (B).
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Figure 5-3. Ultrasonographic assessment of healing.
The figure shows a representative sequence of ultrasonography images recorded
throughout the study of defect filled with bone scaffold (A) and the control (B). Both
defects were created in the same horse. Each sequence within bone scaffold and
control treatment group consist of four images which were recorded at 24h (starting
from top to bottom), 14, 30 and 60 days after the implantation surgery. The images
show increased soft tissue swelling as well as fluid accumulation 14 days after
implantation (second row of images from the top) that was similar in both treatment
groups. The bone scaffold is being gradually covered with bone presented as the
smooth hyperechogenic line (A). In the control defect, bone formation was minimal
and occurred only at the margins of the defect (B).
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Figure 5-4. 3D CT reconstruction.
The figure presents representative 3-D reconstructed computed tomography (CT)
images of the fourth metacarpal bones in same horse. CT images were taken 60
days after implantation and were used for illustration only. The image analysis was
performed on 2D and slab reconstructed images. The defect filled with bone
scaffold is labeled with a white circle. The CT confirmed significant bone formation
within the defect containing bone scaffold as opposed to the control, where bone
formation was minimal.

147

Figure 5-5. Scaffold and control histology.
The figure shows histology at 10x magnification of a section harvested from the
middle of defect filled with bone scaffold (A) and the control (B). The section
harvested from bone scaffold shows bone formation adjacent to pores of bone
scaffold. The tissue harvested from middle of the control defect represents
connective tissue without signs of new bone formation.
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Figure 5-6. Hyaline cartilage formation.
The figure shows a histology image at 100x magnification of a section harvested
from the middle of defect containing bone scaffold. The image shows a new bone
formation with a central island of new cartilage formation (black pointing arrow).
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Figure 5-7. Thermography graph.
The graph shows changes in cutaneous temperature (°C) associated with local
tissues adjacent to created defects. Temperature was measured with infrared
camera over time after surgery.
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Figure 5-8. Radiographic evaluation 2M after surgery.
The comparison between treatment groups in the median values of radiographic
scoring 60 days after implantation surgery

Figure 5-9. Defect density 2M after surgery.
The comparison between treatment groups in mean density the defect measured
in Hounsfield Units (HU) from CT images.
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Abbreviations
CT – Computed Tomography
DBP – Decellularized Bone Particles
DICOM – Digital Imaging and Communications
DLPMO – Dorso-lateral Palmaro-medial Oblique
HU – Hounsfield Units
H&E - Hematoxylin and Eosin
MC IV – fourth metacarpal bone
NBF – Neutral Buffered Formalin
nHA – nanophase Hydroxyapatite
PACS – Picture Archival and Communication System
PU – Polyurethane
ROI – Region of Interest
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Footnotes
a.
b.
c.
d.
e.
f.
g.
h.
i.
j.
k.
l.
m.
n.
o.
p.
q.
r.
s.
t.

NuCress™ bone scaffold, NuShores Biosciences LLC, AR
Gentamicin sulfate,100mg/ml, VetOne®, Boise, ID
Penicillin Procaine G injectable suspension, 300.000 units/ml, VetOne®,
Boise, ID
Firocoxib, Equioxx injectable, 20 mg/ml, Boehringer Ingelheim Animal
Health USA Inc., Duluth, GA
Xylazine hydrochloride, Xylamed, 100 mg/ml, VetOne®, Boise, ID
Ketamine hydrochloride, Zetamine, 100 mg/ml, VetOne®, Boise, ID
Midazolam, 5 mg/ml, Akorn, Ann Arbor, MI
Isoflurane, 250 ml, VetOne®, Boise, ID
PDS II - Polydioxanone #2-0 (3.0 metric) suture with CT-1 36 mm 1/2c
taper needle, Ethicon, Guaynabo, Puerto Rico
SurgiproTM – Polypropylene monofilament #0 (3.5 metric) suture with C17 39 mm 3/8 cutting needle, Covidien, Mansfield, MA
Fluke VT04A Visual IR Thermometer, Fluke Corporation, Everett, WA
NEXT Equine DR™, Sound Technologies, Carlsbad, CA
Logic™ e Vet NextGEN®, Sound Technologies, Carlsbad, CA
Philips® Brilliance-40™, Philips International B.V., Amsterdam,
Netherlands
Sectra® PACS™ IDS7, Sectra AB, Linkoeping, Sweden
Microsoft Office Professional Plus 2016, Microsoft, Redmond, WA
Fiji, ImageJ, National Institute of Mental Health, Bethesda, MD
Neutral Buffered Formalin, Decalcifying solution protocol A, Fisher
Scientific Co LLC, Hampton, NH
IBM® SPSS Statistics™ v.25 Software, IBM, New York, NY
PS Power and Sample Size Calculation, ver 3.0, 2009
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